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8ABSTRACT
Obesity is an increasing health problem all over the world and the prevalence of
overweight increases in every age and social class. Obesity is a multifactorial trait, both
genetic and environmental factors contributing to its development. Although the
combined action of susceptibility genes and environmental risk factors cannot be easily
separated, it has been estimated that 40-80% of the variation in body weight is due to
genetic factors. In recent years, the field of obesity research has focused strongly on
identifying genetic determinants behind rodent and human obesity. To date, well over
200 chromosomal regions have been implicated in obesity or its related traits in different
populations.
This study was carried out to elucidate genetic factors influencing the complex
phenotype of obesity in the Finnish population. The original study sample set included
100 obese sibling pairs ascertained from the Finnish Twin Cohort and the weight-
reducing groups of Helsinki University Central Hospital. Additional sib pairs were
collected later from other hospitals’ weight reducing groups. All the probands and their
siblings were markedly obese having a body-mass index (BMI) equal to or over 32
kg/m2.
Firstly, the newly discovered obesity gene, leptin (ob) was studied. An association was
found between the leptin gene locus and serum leptin levels but no evidence of linkage
or association to obesity could be found. Secondly, several biologically relevant
candidate genes implicated in rodent obesity, were tested for linkage to human obesity.
From seven analyzed gene regions, evidence of linkage to obesity was found on
chromosome 18q21.3 which contains the melanocortin -4 receptor gene. Further,
dissection of the study material into subgroups to homogenize the phenotype
strengthened the linkage yielding a p-value of 0.001. Thirdly, a three-stage genome-wide
scan was carried out to identify novel genetic loci predisposing to obesity in the Finnish
population. Two major findings were a linkage to chromosome Xq24 (maximal lod
score of 3.5) and a linkage to the melanocortin –4 receptor gene. Interestingly, a
positional candidate gene on Xq24 region, the serotonin receptor -2C, has been
implicated in murine and human obesity.
Finally, as a proof-of-principle study, a quantitative trait locus (QTL) analysis of body-
mass index and body height was carried out by combining genotype data from five
Finnish genome scans of different complex traits. With a variance component method no
linkage to BMI could be detected, but the body height revealed strong evidence of
linkage to chromosomes 18q (maximum lod score of 3.0), 7pter (maximum lod score of
2.8) and 12p (maximum lod score of 2.26).
9INTRODUCTION
There are some common beliefs on the origin of obesity, such as “Obesity is the
consequence of gluttony and sloth”. Also, people have observed that obesity runs in
families, therefore “it must be in the genes”. Both aspects are partially correct. Obesity is
a complex disease resulting from a combination of genetic susceptibility, increased
availability of high-energy foods and decreased requirement for physical activity in
modern society. Obesity has reached epidemic proportions in industrialized countries,
and because it is associated with a significant increase in morbidity and mortality
(Kopelman 2000), the health care costs directly attributable to obesity have dramatically
increased over the past few decades (Kuczmarski et al. 1994; WHO 1997). In Finland,
the direct costs for obesity in 1997 were approximately 2.1 billion Finnish marks, or
approximately 4.2 % of the total health care expenditures (Pekurinen et al. 2000). In
addition to the adult population, also the prevalence of obesity in young children and
adolescents has increased (Livingstone 2000). This rapidly expanding problem and the
increasing public health impact have strongly promoted research into the
aetiopathogenesis of the complex phenotype of obesity.
The first law of thermodynamics, which states that the amount of stored energy equals
the difference between energy intake and work, is uniformly applicable to biologic
systems. The primary form in which potential chemical energy is stored in the body is
fat, i.e. triglycerides, due to its hydrophobic nature and high caloric density that permit
extremely efficient way of storage without adverse osmotic consequences (Rosenbaum
et al. 1997). Since the adipose mass tends to be relatively stable over long periods in
most mammals, it was suggested in the 1950s that a homeostatic mechanism monitors
changes in energy stores and elicits compensatory changes in food intake and energy
expenditure to maintain adipose mass at a set point (Kennedy 1953). However, this
homeostatic mechanism tends to function much more efficiently in the “positive”
direction, i.e. the set point is easily exceeded.
In other words, although the human body has excellent physiological mechanisms to
defend against body weight loss, it has only weak physiological mechanisms to defend
against body weight gain when food is abundant. This is related to the hypothesis of the
“thrifty genotype” (Neel 1999) that was proposed several decades ago from studies of
diabetes. It argues that living on the edge of survival for a sufficiently long period had
fixed in the gene pool a collection of alleles that promote storage of fat in times of
plenty. To be conserved in the gene pool, such alleles would have to promote survival in
times of famine to a greater extent than they might imperil health and reproductive
efficiency, even if, as proposed originally, they were to promote type II diabetes directly.
Until a few years ago, the nature of these “thrifty genes” was uncertain, but family
studies and clinical analyses have finally provided encouraging evidence of genes that
contribute to human obesity by altering the efficiency of energy storage in adipocytes
without compromising the survival or reproductive efficiency (Cone 2000).
Obesity is a multifactorial and polygenic trait, and the estimates of its genetic
component, i.e. the heritability, can only be population and time specific. The
predisposing genes and alleles of each individual interact in various ways with different
environments, and thus, it is not evident to predict, how and of which components the
final phenotype was evolved. A susceptibility gene increases the risk for the disease, but
is not absolutely necessary for the expression of the disease: it only lowers the threshold
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for the development of the particular disease. To date, molecular genetic studies have
identified putative loci affecting obesity-related phenotypes in all autosomes and in
chromosome X. The number of genes, markers and chromosomal regions that have been
linked or associated with the human obesity phenotypes is now well above 200
(Chagnon et al. 2000). Specifically, there are about 100 reports of positive associations
pertaining to 40 candidate genes, 44 loci have been linked to obesity or its indicators in
genome scans and other linkage studies. There are over 100 quantitative trait loci
contributing to obesity identified in different animal models. Twenty Mendelian
disorders that have obesity as one of the minor clinical features, have been assigned to a
chromosomal location. Finally, rare human cases of pathological obesity can now be
explained by a mutation in a single gene (Chagnon et al. 2000).
It is important to investigate the molecular mechanisms underlying weight regulation
and feeding, since the results of basic research can be used to develop pharmaceutical
agents to reduce weight. By reducing obesity in society, the health care costs of
associated diseases will presumably also be decreased. However, the ultimate goal of
investigators, the development of medicines starting from the cloning of the disease
gene, will take several years even with the newest technology. In view of this, as far as
the effectiveness in public health care of common diseases is concerned, it may be more
important to control for potential environmental risk factors rather than genetic
determinants because they are more easily influenced in most cases.
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REVIEW OF THE LITERATURE
1. OBESITY: DEFINITION, CAUSES AND CONSEQUENCES
1.1. Definition and measures of obesity
Obesity has been defined by some as a preventable disease in which as excess amount of
fat tissue results from an imbalance between energy intake and energy expenditure
(WHO 1997; WHO 1995). Obesity can be measured by several methods, but the most
widely used and readily available for research purposes is the body-mass index (BMI),
which is easily derived from both objectively measured as well as self-reported data, and
is calculated by dividing weight in kilograms by height in meters squared (kg/m2). This
method was originally developed to eliminate the influence of body height on weight,
i.e. to obtain a measure for relative body weight. Investigations have been made to
determine weight-height index (wt/htn) would be the most suitable for eliminating the
effect of height, and which index would be the most specific for different ages and
populations (Goldbourt and Medalie 1974; Khosla and Lowe 1967). For example, the
ponderal index (kg/m3) is the most suitable weight-height index for newborns. The
adequacy of a certain weight-height index depends also on the selected population, but
on average, the body-mass index (kg/m2) measures relative weight sufficiently well.
Thus, it is widely used internationally and allows comparisons between studies from
different populations.
The body-mass index correlates with body fatness (Gray and Fujioka 1991; Rosenbaum
and Leibel 1988; Strain and Zumoff 1992) and therefore, it is widely used in obesity
studies. However, because height affects the value of BMI non-linearly, in very tall or
very small persons the BMI gives a distorted measure of body fatness. In very tall
individuals, the increase in body fat (excess weight) does not increase the value of BMI
in the same proportion as it does in very small individuals: the increase in BMI equals to
the change of weight (kg) multiplied by 1/(height)2. Furthermore, BMI depends on sex
and age: in women and in older people, fat tissue usually consists a greater portion of
total body mass (Gallagher et al. 1996). Compared with other measures of obesity, BMI
correlates significantly with the waist-to-hip ratio (r=0.52) but less markedly with
skinfold (subscapular/triceps ratio) measurements (r=0.18) (Cardon et al. 1994). To only
measure the proportion of body fat, the underwater-weighting or bioimpedance are more
accurate, and magnetic resonance imaging (MRI) can be used to determine virtually the
exact amount and distribution of fat in each compartment of the body. Yet, these
methods require considerably more resources and thus, may not be available for every
study.
BMI cut-off points for definition of obesity were introduced by the World Health
Organization in 1995 and 1997 (WHO 1997; WHO 1995) (Table 1).
12
Table 1. The body-mass index (BMI) cut-off points proposed by the World Health Organization
to define obesity by different classes.
Body-mass index
(kg/m2)
Weight class
BMI < 20 underweight
20< BMI <25 normal weight
25< BMI <27 slight overweight
27< BMI <30 moderate overweight
30< BMI <35 obesity
35< BMI <40 severe obesity
BMI > 40 morbid obesity
1.2. Prevalence of obesity
The prevalence of obesity is increasing globally and also in undeveloped countries due to
the westernization of lifestyles (Grol et al. 1997; Hodge et al. 1996). According to the
WHO classification (Table 1), 54% of adults in the United States are overweight (BMI ≥
25 kg/m2) and 22% are obese (BMI ≥ 30 kg/m2) (Flegal et al. 1998). The prevalence
trends of weight gain and obesity in European countries are similar to those in the U.S.
(Seidell 1995a) although specific rates are lower.
Compared to European countries, the prevalence of obesity in Finland is high, and it is
highest among the Scandinavian countries (Pietinen et al. 1996). The average BMI is
higher in Finnish men and women than in their Swedish counterparts (Rahkonen et al.
1998). In 1992, the prevalence of overweight (BMI ≥ 25 kg/m2) in Finnish men was 63%
and in women 49%, and the prevalence of obesity (BMI ≥ 30 kg/m2) was 19% in men
and 18% in women. Despite the accentuated rise of being overweight and obesity in
Finland during the past 30 years (Lahti-Koski et al. 2000), severe and morbid obesity
have remained rare, at least when compared to the United States where 8% of the
population is severely obese (Laurier et al. 1992; Pietinen et al. 1996). Only 3.0% of
Finnish men and 5.5% of women were severely obese (BMI ≥ 35 kg/m2) and 0.5% of
men and 2.1% of women were morbidly obese (BMI ≥ 40 kg/m2) in 1992 (Pietinen et al.
1996). These rates might be now higher according to a more recent study (Rahkonen et
al. 1998).
1.3. Aetiology and risk factors for obesity
Body weight is determined by an interaction between genetic and environmental, e.g.
psychosocial, factors acting through the mediators of energy intake and energy
expenditure. Although genetic predisposition is important in gaining weight, the marked
rise in the prevalence of obesity during the past two or three decades is best explained by
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behavioral and environmental changes (Hill and Peters 1998). Our genes are unlikely to
have changed substantially after the Second World War, but the availability of highly
palatable, energy-dense foods and an environment that discourages to physical activity
are more prevalent than ever.
A sedentary lifestyle with decreased physical exercise promotes obesity (Esparza et al.
2000; Heitmann et al. 1997; Williamson et al. 1993) in adults, children and adolescents
(Davies et al. 1995; Maffeis 2000). Of dietary factors that have been associated with
weight gain and obesity, the most important are high fat content (Bray and Popkin 1998),
energy density, pleasantness of taste (i.e. palatability) and dietary variety (McCrory et al.
2000). With respect to behavioral aspects, overweight subjects have been reported to
have more difficulties in controlling eating, stronger feeling of hunger  (Hakala et al.
1999), a tendency to engage in emotional eating (Lindroos et al. 1997) and binge eating
(Wilson et al. 1993). Socioeconomic factors such as low levels of education and income,
and social isolation are associated with weight gain and predictive of the development of
obesity (Kahn and Williamson 1990; Kuczmarski et al. 1994; Pietinen et al. 1996;
Rahkonen et al. 1998; Rissanen et al. 1991).
1.4. Morbidity and mortality associated with obesity
Obesity causes, exacerbates and predisposes to many diseases, e.g. osteoarthritis, cancer
of the breast and colon, hypertension, gallbladder disease (Colditz 1999) and in
particular to coronary heart disease (Hubert et al. 1983; Manson et al. 1990) and to non-
insulin-dependent diabetes mellitus (NIDDM) (Colditz et al. 1995; Olefsky and
Kolterman 1981). Obesity ranks among the major determinants of health care costs in
westernized countries (Seidell 1995b). According to different estimations the direct
health care costs attributable to obesity vary between 2-7 % of the total health care
expenditures in several countries including Finland (Levy et al. 1995; Pekurinen et al.
2000; Seidell 1995b; WHO 1997). In 1997 the direct health care costs of obesity in
Finland were estimated to be 0.9-3.2 billion Finnish marks, and thus obesity represents
even a greater burden to health care than smoking (Pekurinen et al. 2000). In the United
States the direct costs of inactivity and obesity account for some 9.4 % of the national
health care expenditures, and in 1995 the direct costs for obesity (BMI > 30 kg/m2) were
app. 70 billion dollars (Colditz 1999).
Some negative influences of obesity are, to some extent, dependent on the regional
distribution of the adipose tissue. Intra-abdominal visceral fat is a major contributor to
the development of hypertension, elevated plasma insulin concentration and insulin
resistance, NIDDM and hyperlipidaemia (Kopelman 2000). Increased body fat leads to
worsened cardiovascular functions, by increasing total blood volume and cardiac output,
and thus causing structural changes in the heart, e.g. left ventricular dilatation and
myocardial hypertrophy (Lauer et al. 1991). Independent of several traditional risk
factors, body weight is directly associated with the development of congestive heart
failure (Hubert et al. 1983).
The association between overweight and the risk of type II diabetes is linear. In a
prospective population study, in women the risk of diabetes increased fivefold for those
with a BMI of 25 kg/m2, 28-fold for those with BMI of 30 kg/m2 and 93-fold for those
with BMI ≥ 35 kg/m2, compared to controls with BMI ≤ 21 kg/m2 (Colditz et al. 1990).
In men, the risk of diabetes is increased 2.2-fold when 25 ≤ BMI < 27 kg/m2, 6.7-fold
14
when 29 ≤ BMI < 30 kg/m2, and 42-fold for those with BMI ≥ 35 kg/m2 (Chan et al.
1994). Obesity also increases the risk of obstructive sleep apnoea (Kopelman 1992;
Palomaki et al. 1992), certain forms of cancers (den Tonkelaar et al. 1995) and
osteoarthritis of weight bearing joints (Kopelman 2000).
Obesity is associated with increased mortality in both sexes in several studies (Manson
et al. 1995; Troiano et al. 1996). Throughout the range of moderate to severe obesity, the
risk of death due to all causes, e.g. cardiovascular disease and cancer, is increased (Calle
et al. 1999). The risk rises remarkably when the BMI exceeds 32 kg/m2, and when the
BMI exceeds 42 kg/m2, the risk of death is 2.6-fold in men and 2.0-fold in women
compared with normal weight controls (Calle et al. 1999). The association between BMI
and mortality is suggested to be U-shaped, and as an explanation to this, the mortality
related to low BMI could be attributed to confounding factors such as smoking, pre-
existing or chronic diseases (Losonczy et al. 1995). However, Allison et al. showed by
meta-analysis that pre-existing disease does not confound the BMI-mortality association,
or eliminating early deaths is inefficient for reducing that confounding (Allison et al.
1999a). Yet, the risk of dying is a linear increasing function of high fat mass and low fat-
free mass (Heitmann et al. 2000) and the loss of body fat is associated with the decrease
in all-cause mortality (Allison et al. 1999b).
2. GENETIC EPIDEMIOLOGY OF OBESITY
One aim of genetic epidemiology of obesity is to evaluate the relative contribution of
genetic and environmental factors, and their interaction, to the interindividual variability
of body weight. In addition, genetic epidemiology assesses whether the genetic and
environmental effects vary with age, gender and other factors. Such studies to determine
the genetic basis of obesity probably started in the 1920’s and during the following
decades, several articles were published on the issue, based on the weight for height data
of study subjects (Bouchard 1995). However, in the last 20 years, a large number of
studies examining the heritability (h2) of this complex trait, have used other –and more
appropriate- indicators of obesity, such as body-mass index. To date, there is no
consensus on the degree of heritability, and the exact estimates are quite varying. This
presumably informs us about the complex nature of the trait: its heritability can be
influenced by population specific environmental factors varying overtime; also the study
design and method of statistical analysis can affect the values obtained. However, the
majority of studies agree upon that the genetic factors play a significant role in the
causes of individual differences in relative body weight and human adiposity, and
furthermore, only a small proportion of genetic variance is attributed to the
consequences of assortative mating (Maes et al. 1997).
Twin, adoption and family studies provide the basis for genetic epidemiology studies of
obesity. These study models have been recently reviewed (Maes et al. 1997) in the
context of body weight, and it was concluded that h2 estimates from twin studies (0.50-
0.90) are usually higher than those from family studies (0.20-0.80), while adoption
studies provide somewhat lower estimates of h2 (0.20-0.60) for BMI. However, it should
be emphasized that the estimates of genetic effects are dependent on study definitions
and designs: since twin pairs are so well matched by their age and living environment,
their mutual correlation in every trait is usually higher than between other family
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members. Since virtually every trait varies in expression with age, or a trait may be
influenced by different genes at different ages, using twin pairs removes this
confounding factor from consideration (Martin et al. 1997). For the onset of a complex
disease, susceptibility genes increase the risk, but they are not necessarily required for
the development of the disease phenotype. They may only lower the threshold for the
outbreak of the particular disease, playing one role in the complicated network of
interactions with all the other predisposing factors (Figure 1).
Figure 1. Complex diseases are caused by a combination of genetic and environmental factors, which
influence each other differently at different stages of life. When a certain amount of risk factors
predisposing to the disease have accumulated, the threshold level is achieved, and the disease develops.
As well as body weight, body height is also a multifactorial characteristic influenced by
both genetic and environmental factors (Preece 1996). Body height is the denominator of
the BMI, and it is related to BMI non-linearly: the taller the person, the less effect does
excess fat have to his/her relative weight. Several environmental factors at different
stages of life can contribute to a slower growth velocity. For instance, maternal smoking,
malnutrition, diseases, and increased energy expenditure (exercise), can affect the final
stature achieved (Kusin et al. 1992; Post and Kemper 1993; Silventoinen et al. 2000).
Estimates of the heritability of height have been studied in different populations and they
have varied between 0.56 and 0.80 (Crow and Kimura 1970; Roberts et al. 1978;
Stunkard et al. 1986a). In studies of Finnish twins and families, the estimates of h2 have
General
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factors Other genes
Susceptibility 
genes
 Other diseases
Chance
Disease
Prenatal 
 conditions
Time
Specific
environmental
factors
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varied from 0.58 to 0.82, increasing steadily across Finnish birth cohorts born between
1900 and 1957 (Silventoinen et al. 2000; Solomon et al. 1983). This may reflect
differences in the standard of living which has improved from decade to decade (Tanner
1992), i.e. the time- and environment specific factors contributing to the gene
expression.
2.1 Quantification of familial aggregation and risk
The genetic predisposition, or the relative importance of genetic versus environmental
factors as summarized as heritability (h2), for a disease is observed as an increased risk
of the first degree relatives of an affected individual for the disease compared to the risk
of more distant relatives, or the risk of general population. Using this viewpoint, a way
of measuring the heritability, or the degree of familial clustering of a disease, was
proposed by Risch as λr (Risch 1990a). Specifically, λr is defined as [P(AR) / P(A)],
where P(A) is the probability of being affected (i.e. the population prevalence) and
P(AR) is the probability of being affected given that one’s relative of degree R is
affected. Typically, the risk ratio for complex diseases is much lower than for single
gene disorders. Also, Risch has shown that the value of λr decreases as the relationship
between the proband and the relative grows more distant, and the pattern of decrease can
be suggestive of the specific model of gene interaction, e.g. additive or multiplicative
models (Risch 1990a; Risch 1990b). The risk ratio for siblings is denoted as λs, and
explicitly, the higher the λs, the stronger the genetic effect is concluded to be. Further, if 
λs equals to 1.0, there is no genetic component of the disease. As the λr depends on the
population prevalence of the trait, its value could vary between different populations
although the actual heritability of the disease remains the same.
The λr has many useful properties, which make it an important variable in designing and
interpreting genetic studies (Bouchard 1995). It can be used, for instance, to determine
the number of relative pairs necessary to narrow a chromosomal region containing a
putative disease locus to a given length (Kruglyak and Lander 1995). Genetic studies of
obesity have triggered studies of heredity and the values of λr for obesity to help
investigators in study design (Allison et al. 1996). The values of λr were calculated for
different BMI percentile cutoffs above 50th and by increments of 5, and four different
data sets containing different types of relative pairs were used empirically. The results
show that λs (sibling’s relative risk) varies by different data set as well as BMI
percentiles. The value of λs ranges from 1.18 to 11.70 when BMI percentiles linearly
increase from ≥50th to ≥95th (Allison et al. 1996). Therefore, it has been concluded that
in the genetic studies of obesity it is more efficient to use siblings than other relative
pairs and it is more efficient to use the most extreme pairs possible. However, the
number of even extreme pairs needed for high-resolution mapping of obesity loci is
discouragingly high (Allison et al. 1996; Risch and Zhang 1995).
2.2 Family studies
Family studies including first-, second- or third-degree relatives offer a tool to dissect the
familial similarity of a phenotype; is this due to genes, life style, behavioral models or
other environmental factors shared by family members. Similarities between family
members are usually indicated as correlations. The Quebec Family Study, including 409
17
large French Canadian families, provided BMI correlations of 0.23 for parent-offspring,
0.26 for siblings and 0.10 for spouse pairs (Bouchard et al. 1988). In addition to relative
weight or BMI, several phenotypic variants of obesity, e.g. abdominal fat mass and total
fat mass, are shown to have common familial determinants (Rice et al. 1996). However,
studies of small families do not easily permit resolution of shared environmental effects
from genetic effects. For this reason, adoption and twin studies are used. Complex
segregation analysis uses more fully all the information available from large families, but
single major genes have not been identified by such analyses (Maes et al. 1997).
2.3 Adoption studies
The aim of adoption studies is to determine the magnitude of environmental and genetic
effect on a disease phenotype. In principle, the adoptees are compared to both their
adoptive and biological parents, and similarities between the adoptees and their
biological parents suggest a genetic component, whereas similarities with their adoptive
parents are due to the shared environment. Adoption studies might be biased due to the
selection: the adoptive parents and family environment are often chosen to resemble
those of the biological parents. Further, adoptees and foster parents may not necessarily
be representative of the general population due to the circumstances behind adoption,
and often the rigorous screening of potential adoptive parents.
One of the largest complete adoption data sets used to determine the heritability of
weight includes 540 adoptees and their biological as well as adoptive parents from
Denmark. All the study subjects were divided into four weight classes (thin, normal,
overweight and obese) and comparisons produced a significant relation of the weight
class of the adoptee and that of his/her biological parent (p<0.0001 for mothers and
p<0.02 for fathers), but no relations was found to the weight class of the adoptive
parents (Stunkard et al. 1986b). Another study including 357 adoptees from Iowa,
resulted in varying correlation coefficients of 0.08-0.40 for the adoptees and their
biological mothers, but still, the correlation between adoptees and their adoptive parents
was clearly lower (0.09-0.09).
2.4 Twin studies
The basis for twin studies is the comparison of the similarity of monozygotic (MZ) and
dizygotic (DZ) twin pairs. A genetic effect on a disease is suggested, if a higher
concordance is found in MZ than DZ twins. As far as complex diseases are concerned,
the concordance rate of MZ twins is far less than 100%, typically 20-30%, emphasizing
the importance of non-genetic factors in the development of the disease. Deriving the
heritability estimations by comparing the similarity of MZ and DZ twins is called the
classic twin method. A specific model of studying twins reared apart can combine the
best aspects of twin and adoption studies. However, the study material for this design is
relatively rare and could be biased by selection.
Several twin studies have shown that genetic factors have an important role in
determining body weight or body fatness in adults as well as in children and adolescents
(Maes et al. 1997). In addition, the shared family environment does not seem to have a
large effect. For relative weight, the MZ twin correlations are approximately twice as
high as the DZ correlations (r MZ ≈ 2r DZ), which indicate an additive genetic component,
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i.e. the genetic effect is comprised of additive effects of several genes (Martin et al.
1997).
In a study of twin pairs reared apart, including twin pairs from Finland and other
populations, the heritability estimates of BMI varied between 0.50-0.80 (Allison et al.
1996b). According to another study, the heritability of BMI was estimated in twins from
Sweden who were reared apart, with an intrapair correlation coefficient of MZ twins of
0.70 for men and 0.66 for women (Stunkard et al. 1990). A large study including 1638
MZ and 2382 DZ American adult twin pairs concluded that the heritability of that
portion of weight unrelated to height is substantial, i.e. 0.61 for men and 0.73 for women
(Allison et al. 1994). A study using a twin database including US World War II veterans
(1974 MZ and 2097 DZ male twin pairs) established the heritability of relative weight in
that population to be 0.77-0.84 (Stunkard et al. 1986a). The study using a twin register
from Denmark including 535 male and 698 female pairs showed that females had greater
heritability for BMI than males, and that heritability in males increases with age
(Herskind et al. 1996). The specific heritability estimates for BMI were 0.46 for middle-
aged and 0.61 for elderly males, and 0.77 for middle-aged and 0.75 for elderly females.
The extent of the genetic effect on body weight on different ages has been studied in
Finnish twins and based on the cross-sectional data, the heritability seems to be higher at
younger ages whereas the effect of environment appears to increase with age (Korkeila
et al. 1991; Pietiläinen et al. 1999). Based on a nationally representative sample of 4884
Finnish adolescent twins including opposite-sex pairs, it was deduced that in
adolescence, genetic effects seem to account for over 80% of the interindividual
variation of BMI in individuals aged 16 to 17 (Pietiläinen et al. 1999).
3. STRATEGIES FOR SEARCHING FOR GENES OF COMPLEX TRAITS
3.1 The underlying complexities and confounding factors
A complex trait is any phenotype that does not obey the laws of classic Mendelian
inheritance, i.e. dominant, recessive or X-chromosomal, attributable to a single gene
locus. Several factors contribute to the intricacy of these traits making it more difficult to
detect the underlying genes (Lander and Schork 1994). Firstly, mutations in different loci
may produce identical phenotypes, for instance when the genes are involved in the same
biochemical pathway. This phenomenon is called genetic, or non-allelic, heterogeneity.
When different mutations in the same, single gene cause the disease phenotype, it is
called allelic heterogeneity, but it does not usually impede gene mapping by linkage
analysis. An individual can inherit a predisposing allele, but may not manifest the
disease, thus, the penetrance of the disease is incomplete. Alternatively, a phenocopy
occurs when an individual gets the disease solely due to the environment without having
a predisposing allele. Further, some traits require the existence of several mutations in
multiple genes simultaneously before the phenotype develops. The interaction or
synergism of genes, a phenomenon called epistasis, plays a significant role in
multifactorial traits (Frankel and Schork 1996). Epistasis is said to occur when the
combined effect of two or more genes on a phenotype could not have been predicted as
the sum of their individual effects. Often, the particular phenotypic outcome could be
measured by a quantitative, continuous variable. These traits may represent a so-called
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threshold effect, manifested whenever an underlying quantitative variable, influenced by
several genes, exceeds a critical threshold, or an effect requiring the joint action of each
mutation (Lander and Schork 1994).
The mode of inheritance is far from being fully understood in complex traits. In addition
to Mendelian inheritance, there are several other transmission mechanism known,
including mitochondrial inheritance, overdominance, genetic imprinting, and
anticipation. These models can lead to highly variable transmission rates and require
specialized analytical methods. Finally, the high frequency of trait-causing alleles can be
confusing; there might be multiple independent copies of the disease allele segregating
in the pedigree, and some individuals may be homozygous for that allele, in which case
the detection of linkage would be improbable.
3.2 Study designs
3.2.1 Selection of study subjects and population
The task of mapping complex traits can be relieved by careful selection of study
subjects, aiming to collect those individuals that most probably are homozygous and
possess a strong genetic determinant to their phenotype (Lander and Schork 1994). As
was shown by Risch (1990), the higher the relative risk λr, the stronger the genetic
background of the disease, and thus, the easier it is to find the gene. However, the value
of λr could be influenced by environmental factors and vary according the population
prevalence of the disease, and this should be taken into account when comparing
different studies.
An essential aspect is to restrict the phenotype to be as similar as possible between cases.
Thereby, the dissection of the clinical picture should be done carefully when collecting
the study material. It is advisable to concentrate on individuals with early-onset of
disease (Lander and Schork 1994), because the effect of the environment on the
phenotype has likely been less extensive and thus, the heritability probably stronger. A
family history loaded with several affected relatives may signify a higher λr, thus
collecting such families could be productive. Further, one should focus on the extreme
ends of continuous trait by collecting the cases representing the tails of the distribution,
i.e. the most severe and rarest forms of the trait. However, it has been shown that the
extreme sampling is not always the most optimal approach for detecting QTLs (Allison
et al. 1998a).
It is imperative to control for environmental variation and non-genetic risk factors in the
study design of complex diseases (Weiss and Terwilliger 2000) because it is clear that
environmental changes can produce dramatic phenotypic changes. In addition to
controlling post-natal conditions, pre-natal development can also affect phenotypic
expression later in life. Geneticists often disregard the fact that these environmental
conditions can be correlated among siblings, leading to inflated estimates of the genetic
component of the trait (Weiss and Terwilliger 2000). In studies of MZ twins, this type of
confounding factor can be eliminated.
The Finnish population demonstrates the effects of the founder effect and a rapid
expansion a few thousand years ago (Nevanlinna 1972; Norio 2000). Compared to a
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large, cosmopolitan population, Finns have advantages for use in mapping of genetic
diseases, because the number of risk alleles segregating in the population is reduced, and
often there is one major mutation descending from a single founder chromosome
(Peltonen et al. 1999). Due to this, LD (or nonrandom association of alleles at linked
loci) is seen in disease alleles. Using this feature, several genes belonging to the Finnish
disease heritage have been successfully mapped (de la Chapelle and Wright 1998;
Peltonen et al. 1999). The small, homogenous population could be more suitable also in
complex disease mapping providing a higher probability to observe less allelic and locus
heterogeneity. In addition, the environmental, cultural and life-style factors tend to be
similar in small, isolated populations than in large, mixed populations. One of the most
largest projects aiming to collect a nationwide DNA database from an isolated
population has been launched in Iceland, although the genetic homogeneity of this
population has been questioned (Abbott 2000; Arnason et al. 2000).
However, the usefulness of isolated populations in linkage disequilibrium mapping of
complex diseases has been questioned (Kruglyak 1999). Two recent studies have
demonstrated that the level of LD for genetic markers does not differ significantly
between heterogeneous and genetically isolated populations (Eaves et al. 2000; Taillon-
Miller et al. 2000). Specifically, it has been suggested, that even in the Finnish
population the number of founder haplotypes may be relatively high, and common
disease alleles might be more efficiently identified by drift mapping, i.e. LD mapping, in
small old and constant size populations, where the disequilibrium is the result of genetic
drift, and is not due to a founder effect (Terwilliger et al. 1998). One population of this
kind is Saami, or Lapps, that live in close geographic proximity to the Finns. The LD
created by genetic drift does not disappear with time, as opposed to LD in rapidly
expanded populations caused by a founder effect.
3.2.2 Candidate gene approach
A candidate gene approach can be applied when some a priori information of the disease
pathogenesis is known. For example animal models or microarray expression studies can
provide several clues to adequate candidate genes. Based on relevant biological
knowledge of the pathophysiology, metabolic pathways and/or their disruptions,
anatomical sites of signaling routes, tissue expression and different transmitter
molecules that are evidently involved in the development of the disease, the most
probable candidate genes can be selected. Variants of the selected gene are then tested
for association with the disease in populations (case-control study) or for linkage with
the disease in families or sibling pairs. Both the single gene and multifactorial disorders
can be analyzed by this method, and there are several examples of the successful gene
identification obtained by this study approach even in complex diseases. Practically, the
candidate gene design means that several polymorphic marker loci either within or
flanking the selected gene are chosen for analyses. As far as complex diseases are
concerned, failures using this study approach are partly due to the huge variation of
polymorphic loci and predisposing genes in a population. Finally, we still do not know
all metabolic pathways in humans, so any selection of candidate genes will undoubtedly
be insufficient. However, one way to identify potential new candidate genes affecting the
disease pathogenesis is to study the differences of gene expression patterns in normal
and affected tissues (Gill and Sanseau 2000).
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3.2.3 Rodent loci and syntenically conserved human chromosomal regions
Animal studies are an extremely powerful tool in genetic analysis of complex traits.
Experimental crosses of mice and rats offer the opportunity to study hundreds of meiosis
from a single set of parents, thus removing the problem of genetic heterogeneity and
providing possibilities to study far more complex genetic interactions than in human
subjects (Lander and Schork 1994). The most significant advantage of animal models is
seen in their ability to dissect quantitative traits into discrete genetic factors. Nongenetic
noise can be decreased through the use of progeny tests, recombinant inbred strains and
recombinant congenic strains (Groot et al. 1992; Lander and Botstein 1989) which
allows detection of interacting and modifier genes in single-gene traits as well as in QTL
traits.
Studies of animal models may not reveal exactly the same mutations that one would find
in humans because the mutation frequency varies between different species, but they will
help to discover important genes in the same biochemical pathway or physiological
system (Lander and Schork 1994). Animal models have played a very important role in
identification of genes implicated in obesity. To date, there are about a hundred obesity
predisposing genes and loci identified in mice and rats, and many of these regions have
homologues in human. These human counterparts have been under extensive genetic
studies in recent years and significant results have been obtained since the cloning of the
first obesity genes, agouti and leptin (Bultman et al. 1992; Zhang et al. 1994).
3.2.4 Genome-wide scan
When there is no a priori information of the disease pathogenesis -in complex diseases
as is often the case, or when a study focuses on finding novel loci contributing to a
disease, a genome-wide scan may be useful. The principle of genome screening is to
genotype the entire genome with a dense collection of highly polymorphic markers that
are evenly spaced, and then calculate an appropriate linkage statistic at each position
along the genome, and finally identify the regions in which the statistic shows a
significant deviation from what would be expected under independent assortment.
Usually a second stage of fine-mapping is used in the regions showing the strongest
evidence of linkage in order to narrow down the linked chromosomal region (Holmans
and Craddock 1997). To date, microsatellite markers have been used in mapping
projects, but single-nucleotide polymorphism (SNP) based microarray technology may
offer another option, although one would need a tremendously greater density of SNP
than microsatellite markers for adequate screening of the genome (Weiss and Terwilliger
2000).
In genetic studies of complex traits, the study subjects are often well characterized by
detailed phenotyping. However, in some cases, only a minority of the collected
phenotypic data is utilized in analyses of a particular trait, and much of the information
is practically ignored. Thus, there is a waste from both the economical and ecological
points of view. A novel strategy of combining genotypic data from several different
genome scans to study a yet unanalyzed trait, can be recommended in order not to waste
any of the enormous resources already put into genetic mapping projects.
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3.3 Statistical methods in genetic studies of complex traits
3.3.1 Association analysis
Association analysis refers to a case-control study based on the comparison of unrelated
affected and unaffected individuals from a population (Lander and Schork 1994). It does
not require any assumption of the mode of inheritance. The core idea of the study is
population correlation rather than cosegregation within a family. A particular allele is
said to be associated with the trait if its frequency among the affected is significantly
higher than among the unaffected individuals. An important aspect of this type of study
is the selection of the control population because careless choice can lead to erroneous
results. Controls should always be matched to cases by their ethnic background, age, sex
and if possible, environmental influences. To avoid differences in ancestral background,
one should always perform association analysis within a homogenous population, and
use an “internal control”, i.e. parental genotypes, for allele frequencies: those alleles that
are not transmitted to the affected individual serve as control alleles in the analysis
(Lander and Schork 1994). This method is called haplotype relative risk and can be
applied to either alleles or genotypes (Knapp et al. 1993; Terwilliger and Ott 1992). Also
the transmission disequilibrium test (TDT) could be carried out to see whether the
associated risk allele is transmitted from parent to affected child more often than the
“healthy” allele (Spielman et al. 1994). If TDT is used, naturally the differences in
ancestral background do not matter. A positive association does not necessarily mean
that the associated allele causes the disease, rather, it can only occur more often on the
chromosomes carrying the actual mutation (be in linkage disequilibrium with it). A good
example of a locus with multiple disease-associations without causative relationship is
the HLA locus.
3.3.2 Linkage analysis
The basic idea behind linkage analysis is to trace and measure the co-segregation of
disease in a family with marker loci by taking information from putative recombination
events during meiosis. The traditional parametric linkage analysis has been a successful
model for investigating simple Mendelian traits because the power of the method is tied
to the accurate specification of the inheritance patterns (autosomal dominant, autosomal
recessive). In the standard analysis, model parameters such as allele frequencies and
penetrances have to be specified. The indication of linkage is based on the ratio of
likelihoods, L(θ)/L(½), measuring the evidence provided by the pedigree data that the
recombination fraction is equal to θ (<½, linkage) as opposed to being equal to ½ (no
linkage) (Ott 1995). The lod score is the logarithm (base 10) of that ratio of likelihoods,
and traditionally a lod score of 3 or higher has been considered as strong evidence for
linkage. In the parametric approach, the recombination fraction θ between the disease
and marker loci is estimated on the basis of the family data and the mode of inheritance
assumed for the trait. If the inheritance model is defined inaccurately, it usually leads to
overestimation of the recombination fraction, which is then viewed as a nuisance
parameter rather than a good indicator of disease locus position (Ott 1996). If the
parametric linkage analysis is used in complex diseases, a loss of information and power
can be expected as long as the inheritance model, penetrance, and gene frequency
parameters cannot be specifically determined. However, linkage analysis in extended
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families has yielded noteworthy results also in complex diseases (Kuokkanen et al. 1996;
Pajukanta et al. 1998; Pericak-Vance et al. 1991).
Non-parametric models of linkage analysis (so called model-free analysis) have been
developed in order to circumvent the pitfalls caused by wrong assumptions of
inheritance patterns. In the non-parametric model, i.e. allele-sharing method, no
assumptions are made, rather, it aims to show that random Mendelian segregation of
alleles is rejected and thus, affected relatives (e.g. sib pairs) inherit identical copies of
chromosomal regions more often than expected by chance (Faraway 1993; Suarez et al.
1978). Specifically, siblings can inherit 0, 1 or 2 alleles that are copies of the same
parental allele (i.e. identical-by-descent, IBD) and under random segregation, the
expected proportions of these alleles IBD are 25% - 50% - 25% regardless how siblings
are sampled. A significant skewing in the distribution towards excess sharing of alleles
indicates the presence of linkage when concordant pairs are concerned. If the origin of an
inherited allele cannot be unambiguously resolved, e.g. when the parent is homozygous
or both parents have the same genotype, or there is simply no parental data available, the
inherited allele is called identical-by-state (IBS). As the distinction between these two
status (IBD and IBS) is often impossible, the allele-sharing methods require remarkably
large number of affected relative/sib pairs to yield conclusive data when compared to
traditional linkage analysis with families. If the selected method is based only on the
alleles IBS, it is essential to incorporate allele frequency information into the analysis,
since more common alleles will be shared by affected individuals simply because they
are more common and not because they are coupled or associated with disease alleles.
To increase the power to detect linkage and to position a disease susceptibility gene,
multipoint linkage analysis can be used. Using more than a single genetic marker in the
analysis is advantageous especially when markers in the particular region are not fully
informative. Multipoint analysis can be applied to both parametric (model-dependent)
(Lathrop et al. 1984) and non-parametric (model-independent) methods (Kruglyak and
Lander 1995; Weeks and Lange 1992).
3.3.3 Quantitative trait locus (QTL) analysis
Quantitative trait locus (QTL) analysis is based on the assumption that the phenotypic
similarity between two relatives is correlated with the number of alleles shared at a trait-
predisposing locus (Haseman and Elston 1972). In QTL analysis, categorical diagnostic
states are not required, rather, one needs a continuously measurable observation (e.g.
BMI, blood pressure, insulin sensitivity). Statistically, one may perform regression
analysis of the squared difference ∆2 in a trait between two relatives and the number χ of
alleles shared IBD at a locus. When a locus contributing to the variation of the
quantitative trait lies near the tested marker locus (i.e. there is a linkage), there will be a
negative regression of ∆2 on the number of alleles shared IBD; for sibs sharing two
alleles IBD, ∆2 will be small, while for sibs sharing no alleles IBD, ∆2 will be large. A
QTL analysis can be employed for sib pairs (Haseman and Elston 1972) and other
pedigree relations (Amos and Elston 1989; Olson and Wijsman 1993).
The power for detecting linkage in quantitative trait analysis depends on several factors:
the distance between mean phenotype values associated with underlying genotypes, the
underlying allele frequencies, the density of marker coverage, heterozygosity of the
markers used, and the sampling scheme used to collect data (Ghosh and Schork 1996).
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To maximize the power of QTL analysis, several extensions have been developed: a
multipoint analysis with two flanking markers (Goldgar 1990) and with all the markers
along the genome (Kruglyak and Lander 1995). Another way to overcome the power
issue and large sample sizes needed to detect loci of modest effects, is to use selective
sampling of sib pairs (Cardon and Fulker 1994), specifically extreme concordant and
discordant pairs (Risch and Zhang 1995). Focusing on discordant pairs can reduce the
genotyping effort by 10- to 40-fold over conventional designs. Further, all the siblings
meeting the proband’s criteria in the family should be included in the analysis.
To fully use the inheritance information in mapping data variance components (VC)
methods have been recently developed (Amos and Elston 1989; Blangero and Almasy
1997; Fulker and Cherny 1996; Schork 1993). The VC approach have several desirable
features (Williams et al. 1997) due to its generality and flexible model capability: any
type of pedigree structure is accommodated, and virtually any type of effect or
interaction can be incorporated, such as marker-specific effects, residual additive genetic
effects and random environmental effects. The VC method exploits all of the available
inheritance information in a pedigree of any size, and information from all individuals is
used in the analysis, irrespective of affection status or trait value (Williams and Blangero
1999). The fundamental difference between linkage analysis methods and VC methods
concerns the distinction of the dependent and independent variables method (Risch and
Zhang 1995; Schork 1993): in the VC approach to linkage analysis, the IBD status of
relative pairs is accepted as given, and the phenotypic distribution within a pedigree is
compared with that expected under a null model of no linkage –thus the IBD information
is the independent variable that is used to model a dependent phenotype. In the linkage
analysis the situation is reversed. VC methods require assumptions about the phenotypic
distribution, and usually, multivariate normality is assumed. However, this is the major
drawback of the method: when the distributional assumption is violated, the analysis
potentially lacks robustness and exhibits an excess of Type 1 errors (Allison et al.
1999c). There are many important reasons why nonnormality, such as leptokurtosis, of
the phenotypic data might occur (Allison et al. 1999c), and since this problem has to be
dealt with, a correction constant has been proposed (Blangero et al. 2000) to maintain
the strength of the likelihood-based inference.
3.3.4 The issue of statistical significance
In the past, when only simple Mendelian traits were studied by classical two-point
linkage analysis, the level of significance was widely accepted to correspond to lod score
3, equivalent to a p-value of 10-4 (Chotai 1984). A lod score of 3 means that the
observed data is 103 –fold more likely to arise under the specified hypothesis of linkage
than under the null hypothesis of no linkage. This criteria keeps the chance of false
positive at no more than 5% at a specific locus, but on the genome-wide level where
multiple testing imposes, this significance level corresponds to 9% (Lander and
Kruglyak 1995). Thus, in order to avoid excess reporting of false positive “significant”
linkage results in the era of genomic screens of multifactorial traits, more stringent
threshold lod scores have been proposed. Specifically, Lander and Kruglyak (1995)
recommended for sib pair studies that the standard lod score for a suggestive linkage be
equal to 2.2 (p=7×10-4), for a significant linkage the lod score should be 3.6 (p=2×10-5)
and for a highly significant linkage the lod score should be 5.4 (p=3×10-7). However,
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scientist are still encouraged to report all nominal p-values of 0.05 encountered in a
complete genome scan, without any claims of linkage though, because there is still a
chance that small peaks represent weak but true linkages (Lander and Kruglyak 1995).
This information could help other investigators in replicating the regions of interest in
their own material, and thus perhaps attain the level of significance. The proposed
standard lod score values have been reconsidered (Witte et al. 1996) but also found
acceptable and thus been further recommended (Lernmark and Ott 1998). Apart from the
chosen cut-off point for lod scores, another mean has been proposed to distinguish
between true and false positive linkages. Terwilliger and coworkers (Terwilliger et al.
1997) have shown that true peaks are, on average, wider than false peaks of similar
height, and that wider peaks are more likely to contain the disease gene. Further,
statistics that use both the width and height of a potential peak may be more powerful
than a test based on height alone, because it uses more information (Ott 2000).
5. MONOGENIC FORMS OF OBESITY IN RODENTS AND HUMANS
The field of obesity research has benefitted from several animal models providing a new
knowledge and understanding of the complexities underlying the mechanisms of energy
balance, thermogenesis, body fatness and regulation of feeding and satiety. The cloning
of rodent obesity genes (Table 2) has led investigators to search for the same genes and
possible mutations in humans. In a few cases, these studies have been successful. In
addition to serving as tools for studying the function, effects and regulation, animal
models can help to elucidate the anatomical sites of expression of these genes. The
involvement of the hypothalamus in adiposity had been known since 1940 (Hetherington
and Ranson 1940), but a new era in obesity research began in the 1990s when the first
discoveries of the rodent obesity genes agouti and leptin (Lu et al. 1994; Zhang et al.
1994) generated enormous interest in the interaction between peripheral signals and
brain targets involved in the regulation of energy balance and feeding.
In this paragraph, only those animal models of obesity that are widely investigated or
most crucial for this thesis work, are described. To date, several other murine models of
obesity, mainly knock-out mice and rare spontaneous mutations, have been reported.
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Table 2. Single gene mutations in rodent models of obesity and the equivalent human gene.
Modified from Chagnon et al. 2000.
Mutation Rodent Human References
Chr Gene Inheritance Chr Gene Gene product
Diabetes
(db)
4 Lepr Recessive 1p31 Lepr Leptin receptor Tartaglia 95
Fat (fat) 8 Cpe Recessive 4q32 CPE Carboxy-
peptidase E
Naggert 95
Obese (ob) 6 Lep Recessive 7q31.3 Lep Leptin Zhang 94
Tubby
(tub)
7 Tub Recessive 11p15.5 TUB Insulin signaling
protein
Kleyn 96,
Noben-Trauth
96, Kapeller 99
Agouti
yellow (Ay)
2 Ay Dominant 20q11.2 ASIP Agouti signaling
protein
Wilson 95
5.1 Leptin (ob) and leptin receptor (db)
The first evidence for a physiological, homeostatic system for body weight regulation
was deduced in the 1950s (Kennedy 1953) and was reinforced after the discovery of
recessive mutations, obese (ob) and diabetes (db) (Ingalls et al. 1950), and subsequent
parabiosis studies of these strains by Hausberger and Coleman (Coleman 1973;
Hausberger 1959). Their deductions that the ob locus was necessary for the production
of a humoral satiety factor and that the db locus encoded a molecule required for
response to this factor were confirmed by the cloning of the ob and db genes (Tartaglia
et al. 1995; Zhang et al. 1994). For mice, the mutations in the ob gene cause
hyperphagia, early-onset morbid obesity, hypothermia, decreased energy expenditure,
hyperinsulinemia and infertility due to the hypothalamic hypogonadism.  The ob gene
product was named leptin (from the Greek leptos, meaning thin), because when injected
in animals, it led to reduction in food intake, body weight and body fat in addition to the
correction of all the metabolic derangements (Halaas et al. 1995; Pelleymounter et al.
1995).
Leptin is synthesized mainly in white adipose tissue but also in gastric epithelium and
the placenta (Campfield et al. 1995; Pelleymounter et al. 1995). The plasma leptin levels
correlate strongly with leptin mRNA and the mass of the adipose tissue (Considine et al.
1996). The expression of leptin is influenced by several factors, and vice versa, leptin
has many stimulatory and inhibitory effects on the neuroendocrine axis in addition to
body weight regulation and appetite control (Figure 2) (Ahima and Flier 2000). Its role
as the mediator of the adaptation to fasting is manifold. For instance, it serves as an
important link between nutrition and the immune system by stimulating inflammatory
response and T-cell proliferation (Lord et al. 1998), and it is necessary for the maturation
and proper function of the reproductive axis (Chehab 1997; Chehab et al. 1996).  Leptin
stimulates gonadotropin-releasing hormone (GnRH) (Finn et al. 1998) and corticotropin-
releasing hormone (CRH), and a fall in leptin levels suppresses thyroid function by
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decreasing thyrotropin-releasing hormone (TRH) formation (Legradi et al. 1997). Leptin
inhibited glucose-responsive neurons in hypothalamus, and insulin secretion from
pancreatic β-cells is decreased through leptin’s effects on ATP-sensitive potassium
channels (Harvey et al. 1997; Spanswick et al. 1997).
Soon after the discovery of leptin, the leptin receptor gene (Ob-R) was isolated in db/db
mice (Tartaglia et al. 1995) that have a similar phenotype to ob/ob mice in addition to
leptin insensitivity. Ob-R mRNA has multiple splice variants that encode at least six
leptin receptor isoforms (Lee et al. 1996), and only the long isoform (Ob-Rb) contains
the intracellular motifs required for signal transduction and transcription activation
pathway (Ghilardi et al. 1996). The short isoforms are expressed in various tissues, e.g.
the choriod plexus, vascular endothelium, kidney, liver and gonads (Ahima and Flier
2000). The long form of the leptin receptor polypeptide is expressed in hypothalamic
regions implicated in feeding behavior and energy balance, and it is colocalized with the
neuropeptide mediators of leptin action (Figure 2), such as neuropeptide Y (NPY) and
proopiomelanocortin (POMC), agouti-related peptide (AgRP) and cocaine- and
amphetamine-regulated transcript (CART) (Baskin et al. 1999; Elmquist et al. 1999).
Leptin-sensitive neurons may control feeding by influencing the expression of
orexigenic peptides, for instance melanin-concentrating hormone (MCH) and hypocretin.
Further, anorexigenic peptides such as POMC and CART are increased in response to
leptin administration (Kristensen et al. 1998). Potential transmitters of leptin action in
the brain also include corticotropin-releasing hormone (CRH), cholecystokinin (CCK),
.glucagon-like peptide-1 (GLP-1), urocortin, bombesin and serotonin (Flier and Maratos-
Flier 1998).
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Figure 2. Role of leptin in the adaptation to starvation. The fall in levels of leptin with starvation results in
an increase in neuropeptide Y (NPY) and agouti-related peptide (AGRP) levels, and a decrease in pro-
opiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART) levels in the
arcuate hypothalamic nucleus. NPY and AGRP stimulate feeding, whereas α-melanocyte stimulating
hormone (α-MSH), a product of POMC, and CART inhibit feeding. These neurons also project to the
lateral hypothalamus and regulate the expression of the melanin-concentrating hormone (MCH), a major
stimulator of feeding. Additionally, leptin targets in the arcuate hypothalamus respond to low leptin levels
by regulating the neuroendocrine axis and decreasing sympathetic nervous output. A fall in leptin also
leads to suppression of immune function. CRH (corticotropin-releasing hormone), TRH (thyrotropin-
releasing hormone), GHRH (growth hormone-releasing hormone), SS (somatostatin), GnRH
(gonadotropin-releasing hormone), GH (growth hormone). Modified from Ahima and Flier (2000).
Since the leptin gene and its receptor were identified in rodents, their human
counterparts have been targets for intensive genetic study. Equivocal reports exist of
evidence of linkage and no linkage between obesity and chromosomal region 7q31.3
containing the human OB (i.e. LEP) gene (Clement et al. 1996; Norman et al. 1996;
Reed et al. 1996) as well as the OB-R region in chromosome 1p31 (Chagnon et al. 1997;
Gotoda et al. 1997; Thompson et al. 1997). The quantitative phenotype, serum leptin
level, has been significantly linked to chromosome 2p21 in a genome scan of Mexican-
Americans (Comuzzie et al. 1997), to chromosome 5q-cen in a French population
(Hager et al. 1998) and to chromosome 6p12-21 in Pima Indians (Walder et al. 2000).
The mutations in leptin and leptin receptor genes causing recessive obesity syndrome are
extremely rare in human subjects. To date, mutations in the leptin gene has been
reported in only two pedigrees: one consanguineous family of Pakistani origin
(Montague et al. 1997) and the other family of Turkish origin (Strobel et al. 1998). The
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individual mutations of the LEP gene are given in Table 4. These leptin-deficient human
subjects demonstrate early-onset morbid obesity, hyperphagia and hypothalamic
hypogonadism, but unlike the ob/ob mice, they are not hypothermic, hyperglycemic or
hyperinsulinemic. Only one consanguineous family of Kalibian origin has been
described with mutations in the leptin receptor gene (Clement et al. 1998) so far (Table
3). In addition to early-onset morbid obesity, hyperphagia and hypothalamic
hypogonadism, the phenotype of these subjects includes impaired secretion of
thyrotropin and growth hormone. Unlike the db/db mice, the human leptin receptor
deficiency is not associated with hyperglycemia, hypothermia or hypercorticism.
5.2 Agouti (Avy), agouti-related protein (AgRP), agouti signaling protein (ASP) and
mahogany (mg)
Although the genetic defects of agouti and related mouse models are involved in the
over-expression of melanocortin antagonists, and thus could be included in the next
paragraph of melanocortinergic signaling, they are described separately here.
Agouti (A/a) mouse is the oldest known mouse model of obesity. The autosomal
dominant lethal yellow (Ay) mouse was identified already at the turn of the last century
and viable yellow (Avy) was initially described in the 1950s (Silvers and Russel 1979).
Animals heterozygous for the agouti locus were first investigated for their golden yellow
coat color, but the phenotype was further characterized by a syndrome of late-onset
obesity associated with hyperphagia, hyperinsulinemia, hyperglycemia and increased
linear growth as well as an increased propensity for developing tumors (Bultman et al.
1992; Michaud et al. 1994). Cloning and analyses of the agouti gene revealed that the
phenotype is caused by inherited promotor rearrangements at the agouti locus that result
in constitutive ectopic expression of the agouti peptide (Bultman et al. 1992; Duhl et al.
1994; Miller et al. 1993).
Normally, agouti is a paracrine-signaling factor, that is secreted only adjacent to
melanocytes within hair follicle where it blocks the binding of melanocyte-stimulating
hormone (α-MSH) to melanocortin receptor 1 (MC1-R) and thus regulated hair
pigmentation (Lu et al. 1994). In addition to being a potent antagonist of MC1-R, agouti
strongly antagonizes the action of melanocortin peptides at the MC4-R (Figure 3), and to
a lesser degree at the MC2-R, but not at the MC3-R or the MC5-R. (Yang et al. 1997).
The human homolog of mouse agouti gene, agouti signaling protein (ASP, ASIP) was
positionally cloned from the human chromosome 20q11.2 (Kwon et al. 1994), and was
shown to be expressed in adipose tissue, heart, ovary, testis and foreskin. ASP has
similar pharmacological profile as the murine agouti: it is a potent antagonist at human
MC1- and MC4-receptors, relatively weak at MC3- and MC5-R. However, competitive
antagonism is apparent only toward MC1-R (Yang et al. 1997).
The obesity phenotype was hypothesized to result when over-expressed agouti protein
chronically antagonizes melanocortin receptor 4 in hypothalamic areas known to be
involved in the control of food intake and body weight. The most compelling evidence to
support this hypothesis were the findings that targeted disruption of MC4-R signaling
results in knockout mice with a phenotype similar to Ay syndrome (Huszar et al. 1997)
and central administration of MC4-R agonists and antagonists stimulate and inhibit
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feeding behavior, respectively (Fan et al. 1997). Further proof came from isolation of the
agouti-related protein (AgRP) from rodents and humans (Ollmann et al. 1997; Shutter et
al. 1997), a peptide sharing high sequence homology with agouti, and showing strong
binding affinity to central MC3-R and MC4-receptors but very little or no activity at
MC5- and MC1-receptors. Subsequently, it was shown that ubiquitous overexpression of
AgRP results in an obese mouse with a phenotype identical to the agouti mouse, apart
from the normal coat color (Graham et al. 1997; Ollmann et al. 1997).
Figure 3. Agouti protein antagonism of MC1-R and MC4-R blocks the effect of α–melanocyte stimulating
hormone (α–MSH) and leads to yellow coat pigmentation and obesity. Modified from Fisher et al. (1999).
Unlike agouti, the expression pattern of mouse and human AgRP is strikingly alike:
primarily in the hypothalamus and adrenal medulla, and at lower levels in the testis, lung
and kidney. In view of the similar distribution of its “high affinity” receptors MC3- and
MC4-R, it seems likely that AgRP controls their function in the brain in a similar way as
agouti modulates MC1-R signaling in skin.
Homeostatic regulation of the central melanocortin system may be achieved through
changes in the bioavailability of the antagonist (AgRP) rather than the agonist (α-MSH)
(Dinulescu and Cone 2000). The key role of AgRP in regulation of energy homeostasis
is further supported by demonstrations that it is able to stimulate feeding when
administered centrally, and prevents the reduction in food intake caused by
administration of α-MSH (Rossi et al. 1998). In addition, AgRP mRNA in the
hypothalamus is inhibited by leptin and stimulated by fasting (Mizuno and Mobbs 1999).
Two autosomal mutations mahogany (mg) and mahoganoid (md), natural suppressors of
agouti action, were only recently shown to suppress not only the pheomelanin synthesis
in the skin, but the whole obesity syndrome of Ay mice (Dinulescu et al. 1998).
Mahogany is thus involved in the interaction of agouti and melanocortin receptors 1 and
4. Since mg protein has physiological effects also in the absence of Ay mutation, it is
argued that it facilitates the binding of AgRP to MC4-R as well. A chronic increase in
MC4-R signaling could explain the hypermetabolic behavior of mg animals. Based on
the genetic studies, mg cannot suppress the phenotype of either MC1-R or MC4-R
Agouti
MC1-R MC4-R
Skin Hypothalamus
Yellow coat color Obesity
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knockout, thus it would be positioned upstream or at the same level of these receptors
(Nagle et al. 1999).
To date, no evidence of human obesity related to mutations in ASP or AgRP genes has
been reported. Genetic studies have failed to show any linkage to them as well (Hasstedt
et al. 1997; Norman et al. 1996).
5.3 Genes of the melanocortinergic signaling pathway
In the last five years, the important role of melanocortin signaling in the control of
appetite and body weight has been elucidated with murine and human genetic models.
The impact of melanocortins as catabolic mediators of leptin action and satiety-inducing
agents has become evident. In the following paragraph, the melanocortin pathway and its
disruptions are described with examples of genetic defects at the level of synthesis,
processing and receptor signaling.
5.3.1 Pro-opiomelanocortin (POMC) and melanocyte-stimulating hormone (α-MSH)
The first suggestions that melanocyte-stimulating hormone (α-MSH) and adrenocortico-
trophic hormone (ACTH) might play a significant role in central nervous system
functioning come from the 1950s (Ferrari 1958), but the observations of their inhibition
of feeding were made much later (Panskepp et al. 1976; Poggioli et al. 1986). α-MSH
and ACTH are derived from a precursor peptide, pro-opiomelanocortin (POMC), which
is expressed in skin, the pituitary, hypothalamic neurons and the immune system
(Bertagna 1994). In these tissues, POMC is cleaved into smaller peptides including
adrenocorticotrophic hormone (ACTH), β-endorphin and α-, β- and γ-melanocyte-
stimulating hormones (MSH), by specific endoproteases (convertases). Anterior pituitary
corticotrophs express prohormone convertase 1 (PC1) and cleave POMC to ACTH,
while melanotrophs express PC2 and cleave ACTH further to yield α-MSH. The
physiological role of the cleaved peptides is only partly known in mice and humans.
ACTH binds to MC2-R in the adrenal cortex and is an irreplaceable factor in adrenal
steroidogenesis (Axelrod and Reisine 1984) and β-endorphin interacts with opioid
receptors. MSH binds to melanocortin receptors centrally and peripherally: in addition to
its effect on feeding inhibition by MC3- and MC4-R, it has also been implicated to skin
pigmentation in humans, since variants of human MC1-R are associated with red hair
and fair skin (Valverde et al. 1995).
The POMC-expressing neurons in the arcuate nucleus project extensively to the brain
areas thought to regulate feeding and at least 40% of these neurons express mRNA for
leptin receptor (Cheung et al. 1997). POMC expression is increased by leptin and
diminished in hypoleptinaemic states such as fasting or in ob/ob mouse (Thornton et al.
1997). A newly discovered anorexic peptide CART (cocaine- and amphetamine-
regulated transcript) is also expressed in POMC-containing neurons (Kristensen et al.
1998) and appears to co-operate with POMC in mediating the appetite suppression
effects of leptin.
The evidence of POMC involvement in human obesity came from two unrelated
children with syndrome of hypocortisolism (no detectable plasma cortisol or ATCH),
hyperphagia and progressive obesity associated with red hair and fair skin (Krude et al.
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1998). One proband was compound heterozygous for two mutations preventing ACTH
and α-MSH synthesis, the other was homozygous for a nucleotide transversion in the 5’-
UTR (Table 3). The normal phenotype of the heterozygous parents indicated a recessive
mode of inheritance. A putative role for POMC in more common forms of human
obesity has been supported by positive reports of linkage studies. Genome-wide QTL
analysis of Mexican-Americans found a significant linkage to a locus on chromosome
2p21, which encompasses the POMC gene (Comuzzie et al. 1997), and estimated that
this locus accounted for 47% of the variation of the serum leptin levels. Studies on
French and African-Americans subjects have reported the same association (Hager et al.
1998; Rotimi et al. 1999).
The mouse model of POMC deficiency has a similar phenotype as human subjects:
obesity, defective adrenal development and altered pigmentation (Yaswen et al. 1999).
Detailed examination revealed that the weight gain was accompanied by both an increase
in body length and a large increase in serum leptin levels. Further, when mutant mice
were raised on a high-fat diet they gained weight faster than mice raised on standard
chow, and on either diet, the mutants had a greater food intake. This indicates, that
POMC-derived peptides mediate both food intake and bodily food deposition, i.e. they
lack the ability to properly adjust their metabolism to decrease food intake with a higher
caloric supply. When POMC mice were treated with α-MSH agonist, they lost 46% of
their excess weight, and gained it back when the injections were stopped.
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Table 3. Cases of human obesity presumably caused by single gene mutations in leptin receptor (LEPR),
pro-opiomelanocortin (POMC), prohormone convertase 1 (PC1), leptin (LEP) and melanocortin receptor 4
(MC4R). Modified from Chagnon et al. (2000).
Gene Chr Mutation Sex Age BMI
(kg/m2)
Reference
LEPR 1p31 G→A in exon 16 F
F
F
19
13
19
65.5
71.5
52.5
(Clement et al. 1998)
(Clement et al. 1998)
(Clement et al. 1998)
POMC 2p23 G7013T & C 7133
in exon 3
C3804A in exon 2
F
M
3
7
NA
NA
(Krude et al. 1998)
(Krude et al. 1998)
PC1 5q15-q21 Gly483Arg A→C+4
 in intron 5
F 3 NA (Jackson et al. 1997)
LEP 7q31 G398delta
in codon 133
C→T in codon 105
in exon 3
F
M
F
M
F
F
8
2
6
22
34
30
45.8
36.6
32.5
55.8
46.9
54.9
(Montague et al. 1997)
(Montague et al. 1997)
(Strobel et al. 1998)
(Strobel et al. 1998)
(Strobel et al. 1998)
(Ozata et al. 1999)
MC4R 18q21.3 CTCT nt 631-634
deletion in codon
211
GATT insertion
at nt 732 in codon
246
C105A nonsense
mutation in codon 35
(Tyr35X)
GT insertion in
codon 279
C271Y
N62S (homozyg.)
Thr11Ser
Ile170Val
Arg165Trp
M
M
F
F
F
F
M
F
F
F
F
M
F
F
F
M
M
F
F
F
F
4
30
20
43
58
35
24
11
10
17
31
36
8
40
8
17
16
14
47
28
49
28
41
42.1
37.6
51
57
33
30
31.1
45.9
48.2
NA
NA
NA
NA
NA
NA
NA
45
50
64
(Yeo et al. 1998)
(Yeo et al. 1998)
(Hinney et al. 1999)
(Hinney et al. 1999)
(Vaisse et al. 1998)
(Vaisse et al. 1998)
(Vaisse et al. 1998)
(Vaisse et al. 1998)
(Hinney et al. 1999)
(Hinney et al. 1999)
(Hinney et al. 1999)
(Farooqi et al. 2000)
(Farooqi et al. 2000)
(Farooqi et al. 2000)
(Farooqi et al. 2000)
(Farooqi et al. 2000)
(Farooqi et al. 2000)
(Farooqi et al. 2000)
(Vaisse et al. 2000)
(Vaisse et al. 2000)
(Vaisse et al. 2000)
NA= not available; F= female; M= male
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5.3.2 Fat (fat/fat), carboxypeptidase E (CPE) and prohormone convertase 1 (PC1)
Autosomal recessive mouse mutation fat (fat/fat) was found to elicit adult-onset obesity,
infertility but not sterility, and hyperinsulinemia with hypertrophy and hyperplasia of the
islets of Langerhans (Coleman and Eicher 1990). Later, the phenotype was specified to
be hyperproinsulinaemic, which led to the idea, that the defective gene could be involved
in the processing of prohormones including proinsulin. The fat mutation was
subsequently mapped to carboxypeptidase E gene (CPE), an exopeptidase, which co-
operates with prohormone convertases in the proteolytic maturation of many hormone
and neuropeptide precursors (Naggert et al. 1995). A missense mutation (Ser202Pro)
identified in CPE results in abolished enzyme activity in not only islet tissue, but also in
the pituitary and brain. As transgenic replacement of CPE activity in the islets of fat
animals did not correct obesity, it was deduced that excess weight gain results from
defects in exopeptidase processing of a number of neuroendocrine or endocrine
prohormones and not islet dysfunction (Naggert et al. 1995). To date, the cause of
obesity in fat/fat mice is still a mystery, although the defective processing of several
neuropeptides offers a tantalizing explanation: the CPE dysfunction will affect numerous
neuropeptides controlling satiety, e.g. glucagon-like peptide 1 (GLP1), neurotensin, pro-
opiomelanocortin (POMC), as well as orexigenic neuropeptide Y (NPY) and melanin
concentrating hormone (MCH) (Yeo et al. 2000). The human CPE gene has been
assigned to chromosome 4 (Hall et al. 1993), but thus far, no human mutations have
been reported.
In 1995, O’Rahilly and co-workers (O'Rahilly et al. 1995) reported a woman with a
novel syndrome suggestive of defective prohormone processing. Her phenotype included
extreme childhood obesity (36 kg at 3 years), reactive hypoglycemia and
hypogonadotrophic hypogonadism as well as greatly increased ratios of proinsulin to
insulin and POMC to ACTH. Altogether, her clinical picture was remarkably similar to
fat/fat mouse. Given the particular form of proinsulin in her plasma, a defect in
prohormone convertase 1 (PC1) seemed most likely, and subsequently, this patient was
found to be compound heterozygous for deleterious mutations in the PC1 gene (Table 4)
(Jackson et al. 1997). Each of the patient’s four children carried one mutated PC1 allele,
but were clinically unaffected.
The expression of PC1 is restricted to the neuroendocrine tissues where it acts
proximally to CPE in the pathway of post-translational processing of prohormones and
neuropeptides. PC1 causes preferential cleavage at pairs of basic amino acids from their
substrates in acidic vesicles, and subsequently, the exposed C-terminal basic residues of
PC1 are removed by carboxypeptidases (Leibel 1997). Other convertases may
compensate for reduced PC1 activity, e.g. PC2, PC5, as in the fat/fat mouse, where other
carboxypeptidases partially compensate for deficient CPE activity (Naggert et al. 1995).
Interestingly, mice with null PC2 alleles are not obese although PC2 is shown to be
necessary for the formation of α-MSH from POMC as well as for processing of other
anorexic peptides such as corticotropin releasing hormone (CRH) and neurotensin
(Perone et al. 1996; Zhou et al. 1993). To date, the exact physiologic mechanism
responsible for the human obesity in PC1 deficiency is not known, further investigations
are eagerly awaited.
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5.3.3 Melanocortin receptors 3 and 4 (MC3-R, MC4-R)
There are five known melanocortin receptors based on the sequence homology ranging
from 35-60% homology between the members (Cone et al. 1996) and they all belong to
the G-protein coupled receptor family. Firstly, the MC1-R was recognized in
melanocytes, and MC2-R was identified from the adrenal cortex, but very little was
known about the function of MC3- and MC4-R at the time when the agouti gene was
cloned in 1992. After the puzzling observations that agouti protein is a potent antagonist
of not only MC1-R but also MC4-R and that MC4-R is largely expressed in the brain,
the picture became clear. The absolute role of MC4-R in the development of obesity was
finally proved with the MC4R-/- knockout (KO) mouse recapitulating the Ay syndrome
(Huszar et al. 1997). The gene disruption in KO-mice resulted in maturity-onset obesity,
hyperphagia (50% increased food intake), hyperinsulinaemia, hyperglycaemia, adipocyte
hypertrophy and increased linear growth of app. 10%. Heterozygotes for the null MC4R
allele exhibit a phenotype intermediate between that of wild-type and homozygous
littermates. The extent of hyperglycemia and hyperinsulinaemia in KO-mice is gender
dependent, with males exhibiting more severe elevation than females in both cases.
Additional evidence was provided by studies showing that, in a dose-dependent manner,
MC4-R integrates an agonist (food inhibition) signal provided by α-MSH (Fan et al.
1997) and antagonist (food intake) signal provided by AgRP in neurons distinct from the
POMC neurons in the hypothalamic arcuate nucleus (Graham et al. 1997; Ollmann et al.
1997).
Human MC4-R is a single exon gene localized in chromosome 18q22 and encodes a
332-amino acid protein (Gantz et al. 1993). The impact of MC4-R on human obesity has
been studied eagerly since 1997 and the first reports gave inconclusive results. Linkage
and association with obesity phenotypes (BMI, fat mass, %fat) were detected for both
MC4-R and MC5-R in the Canadian Family study (Chagnon et al. 1997), the latter
showing more significant linkage. A missense variance Val103Ile was first detected in
British males (Gotoda et al. 1997) but was not associated with obesity. An amino acid
substitution severely impairing the receptor function (Ile137Thr) associated with obesity
as well as several allelic variants have been reported in morbidly obese subjects (Gu et
al. 1999). The first impressive evidence of dominantly inherited human obesity
associated with mutations in the MC4-R gene were reported in 1998 when systematic
mutation screening first revealed three different haploinsufficiency mutations in
European populations (Table 3) (Hinney et al. 1999; Vaisse et al. 1998; Yeo et al. 1998).
The following large-scale sequencing studies have established the MC4-R mutations
heterogeneous and the most frequent (3-4%) cause of monogenic human obesity to date
(Farooqi et al. 2000; Vaisse et al. 2000).
The clinical features of heterozygous MC4-R mutant subjects include hyperphagia,
hyperinsulinemia, no impairment in adrenal or reproductive functions, a tendency toward
a tall stature, and a greater degree of adiposity in females. Further, these human carriers
seem to be relatively healthy, they display a common, non-syndromic form of obesity,
which can be associated also with moderate obesity especially in males (Sina et al.
1999). In MC4-R deficient children, increased growth velocity, greater bone mineral
density and advancement of bone age were observed, and the pubertal development was
intact (Farooqi et al. 2000). All these characteristics are consistent with the murine data,
and suggestive of haploinsufficiency rather than dominant negativity. The variable
penetrance and expressivity of obesity in heterozygous individuals argues that MC4-R
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acts in concert with a number of other genes to regulate energy storage (Cone 2000).
The first description of homozygous MC4-R mutations (N62S) in humans with a
recessive mode of inheritance, was a large consanguineous family of Pakistani origin
(Farooqi et al. 2000). In this pedigree, none of the heterozygous parents had BMI ≥ 30
kg/m2. Functional studies of this mutation provided explanation: in contrast to
dominantly inherited missense and nonsense mutations, N62S mutation retains some
capacity to signal to cAMP generation. Thus, one partially functioning N62S allele
appears to be sufficient to prevent the development of morbid obesity. The homeostatic
control of body weight seems to be sensitive to quantitative variation of MC4-R
expression, i.e. MC4-R may represent a tightly regulated control point in the system.
Pharmacologically thought, MC4-R represents an exciting therapeutic target, since it has
an anatomically restricted expression pattern and its dysfunction gives a quite “pure”
obesity phenotype (Yeo et al. 2000).
Figure 4. Proposed model for MC4-R in the leptin signaling pathway. The sites of disruption of the
pathway that occur in different mouse models are shown.  Modified from Fisher et al. (1999).
Melanocortin receptor 3 is primarily found in the CNS, but expressed also in placenta,
gut, pancreas, adipose tissue, skeletal muscle, kidney and heart (Wikberg 1999). The
human MC3-R maps to chromosome 20q (Magenis et al. 1994) and a QTL analysis has
found a linkage between this locus and subcutaneous fat mass as well as fasting insulin
levels (Lembertas et al. 1997). By contrast, no linkage of obesity to MC3-R was found
by Li et al. (Li et al. 2000) The involvement of MC3-R in the regulation of energy
homeostasis has been evaluated recently with the creation of a MC3R-/- mouse and a
double KO-mouse MC3R-/- × MC4R-/- (Chen et al. 2000). Despite being hypophagic and
maintaining normal metabolic rate, MC3R-/- mice have increased fat mass, reduced lean
mass and higher feed efficiency (i.e. ratio of weight gain to food intake). They are
hyperleptinaemic (due to the increased fat mass), they have normal corticosterone and
thyroxine levels, and male mice develop mild hyperinsulinaemia. Furthermore,  the bone
and body length were shorter than in their wild-type littermates, but the bone mineral
content was normal. Increased fat mass was predominantly due to adipocyte hypertrophy
Obesity ↑ Leptin (ob)
ob/ob agouti
db/db
Ob-R
MC4-R
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↑ POMC
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as in mice expressing agouti or AgRP – natural antagonists of MC3- and MC4-R -
ectopically (Graham et al. 1997). When MC3R-/- animals were exposed to regular or
high-fat diet, they consumed normal or decreased amounts of food, yet gained more
body weight than either wild-type or heterozygous MC3R-/+ mice. Thus, the increased
feed efficiency, not hyperphagia, contributes to greater fat mass and reduced lean mass,
i.e. nutrients are preferentially partitioned into fat at the expense of lean mass (Chen et
al. 2000).
To better understand the differences between MC3R-/- and MC4R-/- mice, double KO-
mice MC3R-/- × MC4R-/- was created (Chen et al. 2000). Because these mice were
significantly heavier than mice lacking only MC4-R, it was concluded that MC3-R and
MC4-R serve non-redundant roles in the regulation of energy homeostasis. One possible
explanation for the finding is that double KO-mice eat excessively, due to the MC4-R
deficiency, and store ingested calories more efficiently, due to the absence of both
receptors (Cummings and Schwartz 2000). Mutations at the MC3-R locus could
contribute in part to the “thrifty genotype”, a putative collection of alleles that were
positively selected over evolution because they promote fat storage in times of plenty,
thus protecting against times of famine (Neel 1999). Leptin and its receptors are poor
thrifty gene candidates, as their mutation cause also infertility, thus preventing positive
selection. In contrast, melanocortin receptors are perfect candidates, as their allelic
variations associated with haploinsufficiency should promote fat storage without
impairing fertility (Cummings and Schwartz 2000).
5.4 Tubby (tub)
Tubby (tub/tub) is a spontaneous autosomal recessive mutation in mice that causes
slowly progressing maturity-onset obesity, insulin resistance as well as cochlear and
retinal degeneration (Coleman and Eicher 1990; Ohlemiller et al. 1995). Tubby mice are
not sterile, but they become infertile after significant obesity develops. The insulin
resistance develops gradually with their weight gain but does not progress to overt
diabetes. Despite hyperactivity of their islet β-cells, tubby mice have almost normal
glucose levels, they are also normocorticoidaemic.
The identity of the mutated tub gene was determined by positional cloning (Kleyn et al.
1996; Noben-Trauth et al. 1996) and it was shown to be a member of a novel gene
family encoding proteins of unknown function that are highly conserved across species
(North et al. 1997). The tub mutation was mapped to mouse chromosome 7 and the
human homolog of tub to the syntenic region of chromosome 11p15 (Chung et al. 1996).
The tub mutation is a G→T transversion resulting in an aberrant transcript where the C-
terminal 44 amino acids are substituted with 24 different amino acids encoded by the
intron. The aberrant tub mRNA is expressed at elevated levels in tubby mice (Kleyn et
al. 1996) but no mutant Tub protein could be detected in brain lysates of these mice
(Stubdal et al. 2000). This indicates a defect at the posttranscriptional level, generation
of an unstable protein and thus, reflects an attempt to upregulate the Tub expression.
Normally, the Tub protein is expressed strongly in the key hypothalamic nuclei that have
been implicated in the central control of energy homeostasis. It is also strongly expressed
in the eye and testis, and moderately expressed in ovary, lung, thymus, intestine and
adipose tissue (Kapeller et al. 1999; Noben-Trauth et al. 1996). The expression of Tub
protein is not significantly altered in ob, db or MC4R -deficient mouse models of obesity
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(Stubdal et al. 2000).
It was demonstrated that tubby is a loss-of-function mutation by generation of a tub-/-
knockout mouse which replicated the whole spectrum of tubby phenotype (Stubdal et al.
2000). Further, it was shown that loss of photoreceptors in the retina in these mice
occurs by apoptosis. Strikingly, in humans, a mutation in Tub-like protein 1 (TULP1)
belonging to the tub gene family, was found to cause an autosomal recessive form of
retinitis pigmentosa (RP14) (Banerjee et al. 1998; Hagstrom et al. 1998). It is possible,
that late-onset obesity of tubby mice could be due to the apoptotic loss of cells in the
hypothalamic nuclei, but thus far, no cellular alterations in the hypothalamus of these
mice have been found (Stubdal et al. 2000). The first evidence of the biological function
of the Tub protein implicates it in intracellular signaling by insulin (Kapeller et al.
1999). It was shown that insulin and insulin-like growth factor 1 (IGF-1) can induce
tyrosine phosphorylation of Tub, and upon phosphorylation, Tub associated selectively
with the Src homology 2 (SH2) domain –containing proteins. Thus, Tub may function as
an intracellular adaptor protein, and in tubby mice, the central insulin-mediated
regulation of energy homeostasis may be disrupted resulting in weight gain and in
insulin resistance (Kapeller et al. 1999). By structure-based functional analysis Tubby-
like proteins were suggested to be a unique family of bipartite trancription factors
(Boggon et al. 1999).
 Interestingly, the tubby phenotype resembles human syndromes with sensory deficits
and obesity such as Alström’s and Bardet-Biedl (BBS) that are characterized by
combined hair cell and retinal photoreceptor loss accompanied by infertility and
moderate late-onset obesity (Bray 1995; Kwitek-Black et al. 1993). To date, six loci for
BBS have been mapped (Table 4) and of these, only one gene for BBS has been
conclusively identified thus far (Katsanis et al. 2000). This gene, MKKS (from
McKusick-Kaufman syndrome), is located in human chromosome 20p12 and encodes a
chaperonin-like protein. It was deduced that a complete loss of function of the MKKS
product leads to an inability to fold a range of target proteins and thereby generates the
clinical picture of Bardet-Biedl syndrome (Katsanis et al. 2000).
5.5 Serotonin receptor 2C (5HT2CR)
Serotonin (5-HT) is a monoaminergic neurotransmitter presumed to modulate several
motor, behavioral and sensory processes through a large family of G-protein coupled
receptor subtypes that are widely expressed in the brain and spinal cord (Peroutka et al.
1990). The serotonergic system in the brain has been strongly implicated in the
regulation of eating behavior and body weight by studies demonstrating the anorectic
effect of drugs that stimulate postsynaptic 5-HT receptors (Blundell et al. 1995; Heisler
et al. 1998; Leibowitz and Alexander 1998; Simansky 1996). The human 5-HT2C
receptor subtype has been cloned (Saltzman et al. 1991) and localized in chromosome
Xq24 (Milatovich et al. 1992). More specifically, this receptor subtype has been shown
to play the key role in appetite regulation (Baxter et al. 1995; Curzon et al. 1997): a
treatment of obese subjects with 5-HT2C receptor agonist decreased subjective feelings
of hunger and caused weight loss (Sargent et al. 1997). 5-HT2C receptors have also been
implicated in eating disorders such as binge eating and bulimia nervosa, where
dysfunction and reduced response of this receptor has been reported (Dourish 1995;
Jimerson et al. 1997; Wolfe et al. 1997).
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To investigate the function of 5-HT2C receptor, knock-out (KO) mice 5HT2CR
-/- were
created (Nonogaki et al. 1998; Tecott et al. 1995). These mutant mice are hyperphagic
and develop “middle-aged” –onset obesity and as these mice age, they develop insulin
resistance and impaired glucose tolerance in addition to increased leptin levels compared
to wild-type littermates (Nonogaki et al. 1998). The 5HT2CR mutation also enhanced
the sensitivity of animals to high-fat diet induced obesity. Since the young mutant mice
had normal plasma leptin levels and normal sensitivity to exogenous leptin
administration, it was deduced that 5-HT2C receptors are not required for leptin action
and hyperphagia is not likely to result from perturbed leptin signaling in these mice. In
other words, hyperphagia per se does not seem to alter leptin action in young animals.
The 5HT2CR mutation primarily produces a dysregulation of food consumption rather
than a deficit in the regulation of carbohydrate or fat metabolism. Hyperphagia leads to
the development of late-onset obesity and insulin resistance. As young 5HT2CR-/- mice
are not obese despite prolonged hyperphagia, this could indicate a presence of
compensatory elevation of energy expenditure. Thus, “middle-aged” obesity in these
mice could reflect an age-dependent decrement in the ability to compensate for elevated
food consumption, and may lead to secondary decrease in leptin and insulin sensitivity
(Nonogaki et al. 1998).
There is a common polymorphism in the human 5HT2CR gene, present in 10-20% of
Caucasians, in which serine is substituted for cysteine in codon 23 (Lappalainen et al.
1995). Although this variation does not affect basal responses to 5-HT, the binding
affinity of 5HT2CR agonist is altered (Malhotra et al. 1996). The role of the Cys23Ser
substitution has been studied with regard to the development of human obesity as well as
eating disorders (Burnet et al. 1999; Lentes et al. 1997), but no relation has been
detected. The 5’-flanking region of the 5HT2CR contains regulatory regions and a
putative transcription factor binding site (Shih et al. 1996). To find a polymorphism that
could alter the expression level of the receptor this region was investigated in 123 obese
(BMI ≥ 28 kg/m2) and 466 non-obese (BMI < 28 kg/m2) Japanese male patients of
whom 138 had NIDDM (Yuan et al. 2000). Three loci of single nucleotide substitution
(G→A at –995, C→T at –759, G→C at –697) and a (GT)n dinucleotide repeat
polymorphism at –1027 were identified. Of these polymorphisms, ten different
haplotypes, five of which are rare, were constructed. The haplotype-based analysis
showed a clear association of the polymorphisms with obesity (p=0.005). Haplotype “3”
containing all of the substitutions was associated with leanness (p=0.02) and with
glucose tolerance, i.e. it was more common in non-diabetic subjects (p=0.033).
Haplotype “9” was associated with obesity (p=0.007). Furthermore, haplotype “3”
showed increased promoter activity compared with the wild type. Thus, it was suggested
that the nucleotide substitutions could be associated with the transcription level of the 5-
HT2C receptor gene and contribute to the genetic resistance to obesity and NIDDM
(Yuan et al. 2000).
5.7 Rare congenital syndromes associated with obesity in humans
There are several Mendelian disorders listed in the OMIM (Online Mendelian
Inheritance in Man) database, that exhibit obesity as one of their clinical manifestations.
To date, twenty of these disorders have been mapped to a specific chromosomal location
(Chagnon et al. 2000). Nine syndromes follow the autosomal dominant inheritance
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pattern, six of them are inherited recessively in autosomes and five disorders are X-
linked. The syndromes are listed in Table 4 with their chromosomal location and
putative candidate genes, if known.
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Table 4. Obesity-related Mendelian disorders with known map location. Modified from
Chagnon et al. 2000.
Mode of
inheri-
tance
Syndrome Candidate
gene
Locus Reference
Autosomal
dominant
Achondroplasia (ACH)
Albright Hereditary Osteodystrophy
(AHO)
Albright Hereditary Osteodystrophy 2
(AHO2)
Angelman Syndrome with Obesity
(AGS)
Posterior Polymorphous corneal
Dystrophy (PPCD)
Insulin Resistance Syndromes (IRS)
Familial Partial Lipodystrophy
Dunnigan (FPLD)
Ulnar-Mammary Schinzel Syndrome
(UMS)
Thyroid Hormone Resistance
Syndrome (THRS)
FGFR3
GNAS1
INSR
TBX3
THRB
4p16.3
20q13.2
15q
15q11-q13
20q11
19p13.3
1q21-q22
12q23-24.1
3p24.3
(Shiang et al. 1994),
(Superti-Furga et al. 1995)
(Patten et al. 1990),
(Schwindinger et al. 1994)
(Hedeland et al. 1992)
(Gillessen-Kaesbach et al.
1999)
NA
(Wertheimer et al. 1994)
(Kim et al. 1992)
(Anderson et al. 1999)
(Bamshad et al. 1997)
(Behr et al. 1997)
Autosomal
recessive
Alström Syndrome (ALMS1)
Bardet-Biedl Syndrome 1 BBS1
Bardet-Biedl Syndrome 2 BBS2
Bardet-Biedl Syndrome 3 BBS3
Bardet-Biedl Syndrome 4 BBS4
Bardet-Biedl Syndrome 5 BBS5
Bardet-Biedl Syndrome 6 BBS6
Berardinelli-Seip Congenital
Lipodystrophy (BSCL)
Cohen Syndrome (COH1)
Carbohydrate-Deficient Glycoprotein
Syndrome Type IA (CDGS1A)
Fanconi-Bickel Syndrome (FBS)
MYO9A
MKKS
PMM2
SLC2A2
2p13-p12
11q13
16q21
3p13-p12
15q22.3-q23
2q31
20p12
9q34
8q22-q23
16p13
3q26.1-26.3
(Macari et al. 1998)
NA
NA
NA
(Gorman et al. 1999)
(Young et al. 1999)
(Katsanis et al. 2000)
(Garg et al. 1999)
NA
(Matthijs et al. 1997)
(Santer et al. 1997)
X-chromo-
somal
Borjeson-Forssman-Lehmann
Syndrome (BFLS)
Choroideremia with Deafness (CHOD)
Mehmo Syndrome (MEHMO)
Simpson-Golabi-Behmel 1 (SGBS1)
Simpson-Golabi-Behmel   2 (SGBS2)
Wilson-Turner Syndrome (WTS)
FGF13 Xq26.3
Xq21.1-q21
Xp22.13-p21
Xq26
Xp22
Xp21.3-q22
(Gecz et al. 1999)
NA
NA
(Pilia et al. 1996)
(Brzustowicz et al. 1999)
NA
NA= not available
42
AIMS OF THE PRESENT STUDY
This study was carried out to investigate the genetic loci predisposing to obesity in
Finnish sib pair material. In order to clarify the underlying genetic component of this
multifactorial trait, three different strategies were applied: an analysis of candidate genes
and candidate regions, a genome-wide screen of obesity, and finally, a quantitative trait
locus analysis of body weight and height.
1. To investigate the role of biologically relevant candidate genes and genomic regions
previously assigned in the animal models of obesity (I, II).
2. To search for new genetic loci predisposing to obesity by performing a genome-wide
scan (III).
3. To identify loci influencing body weight and height by carrying out a quantitative trait
locus analysis using genome scans of several study samples, mostly non-ascertained
for obesity (IV).
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MATERIALS AND METHODS
1. STUDY SUBJECTS
Study subjects were ascertained from two different sources for studies I, II and III,
namely via the Helsinki University Central Hospital and the Finnish Twin cohort. For
the study IV, several different sib pair study samples were combined.
1.1 Morbidly obese and control subjects in the association studies (I, III)
The morbidly obese study subjects had participated in the weight reduction program of
the Helsinki University Central Hospital (HUCH) from 1989-1995. Altogether 420
invitation letters were sent to these patients, of which 254 (61%) patients were finally
invited to the study examination. They all had had body-mass indexes (BMI) equal to or
more than 40 kg/m2 (at the time of the original recruitment their mean BMI was 45.3 ±
5.5 kg/m2) and they were aged 21-64. The study group consisted of 184 women (72%)
and 70 men (28%) with a mean age of 49 ± 9 years. Of these, 116 subjects (46%) were
treated for hypertension and 59 (23%) subjects had type 2 diabetes. All the selected
study subjects were weighed and their height and blood pressure were measured. A 12-
hour fasting blood sample was drawn for DNA analysis and to measure serum lipid,
glucose and insulin concentrations. All the study subjects were asked to fill out a
questionnaire about their general medical history and medication, history of weight
development and attempts to lose weight, exercise habits, consumption of stimulants,
and the height and maximal weight of their first-degree relatives.
For the control group, 151 non-obese and apparently healthy subjects were ascertained
from the same geographical area of Helsinki and its surroundings as the obese study
subjects. The lean group consisted of 65 males and 86 females with the mean age 40 ±
11 years, and they all had BMI less or equal to 25 kg/m2 (mean 22.3 ± 1.9 kg/m2). All the
subjects were unrelated and of Finnish origin. A venous blood sample was taken from all
subjects for DNA analyses with the informed consent of study participants.
1.2 Affected sib and twin pairs and their family members (I, II, III)
A total of 105 sib pairs concordant for obesity from 92 families were ascertained through
two different channels: firstly from the weight-reduction program of the HUCH (the one
that was used to association analysis in study I) and secondly the Finnish Twin Cohort
(Kaprio et al. 1978). The Finnish Twin Cohort consists of Finnish twin pairs (n=13888),
born before 1958, including samples of same-sexed pairs, both monozygotic and
dizygotic. Later, the Twin Cohort has been expanded also to include opposite-sex twin
pairs (Silventoinen 2000). Surveys of the entire cohort have been carried out at regular
intervals to collect longitudinal data on e.g. environmental and genetic risk factors
(Kaprio 1994; Korkeila et al. 1991).
In the weight-reduction group (n=254), 58 probands having one or more obese siblings
(BMI ≥ 32 kg/m2 ) were selected for the sib pair study. A physical examination was
conducted on the recruited sib pairs. Information about their medical history including
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the development and stability of body weight, previous and present illnesses, use of
medication, consumption of alcohol and cigarettes and exercise habits was obtained by
interviewing the patients. The parents of the sibling pair were ascertained when possible,
and a blood sample as well as a detailed health questionnaire was collected from them.
The additional 46 sibpairs from 34 families were ascertained from the dizygotic twin
pairs, who replied in 1975, 1981 or 1990 to the mailed questionnaires of the Finnish
Twin Cohort. These twins were same-sexed and born before 1958 (e.g. aged 38-67 at the
time of this study). Each twin survey questionnaire contains items on weight and height,
and those pairs in which both twins had had BMI ≥ 32 kg/m2 were identified, and invited
to participate in the study. A detailed health questionnaire was then sent to the selected
twins, as well as their sibs and parents. The participating twin pairs were asked to give a
blood sample for DNA analysis at their local health center, where their height and
weight were also recorded.
Since it is important in a sib pair study to obtain maximum information for the phase
determination, all the available parents, or an additional affected sibling, were collected.
Both parents were available in 16 (17%) families and one parent was available in 24
(26%) families, and additional sibs were ascertained in 11 families (12%) leaving 45 sib
pairs with no additional phase information. In ten of the 92 families there were three
obese siblings in a sibship, and in two families there were four obese siblings. The
remaining 80 families had two obese sibs in a sibship.
The characteristics of the sib pair material are given in Table 5.
1.2.1 Replication material (III)
To replicate the results of the genome scan (study III) in another sample set, an
additional 93 affected sib pairs from 79 Finnish families were collected through three
new weight-reduction groups. These patients had participated in the program at the
Helsinki University Central Hospital, at the Tampere University Hospital and at Peijas
Hospital in Vantaa. All the selected probands as well as their recruited siblings had BMI
≥ 30 kg/m2. In 70 of these families, there were two affected siblings in a sibship, in six
families there were three affected, in two families there were four affected and in one
family there were five affected siblings. Parent(s) were available for three of those
families that had only two affected sibs. A detailed questionnaire was mailed to all the
selected subjects and they were asked to give a blood sample for DNA analysis at their
local health center, where their height and weight were recorded. The characteristics of
the replication material are given in Table 5.
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Table 5. The characteristics of the two study groups, the primary genome scan sample set
containing 100 sib pairs and the replication sample set containing 93 sib pairs.
Height
(cm)*
Weight
(kg)*
BMI
(kg/m2)*
Females
(n)
Males
(n)
Primary
sample set 166.3 ± 8.7 101.7 ± 20.2 36.7 ± 6.1 125 63
Replication
sample set 170.0 ± 9.5 105.6 ± 20.9 36.5 ± 6.5 91 80
*The mean and standard deviation
1.3 Study samples for the combined QTL analysis (IV)
The subjects for the QTL analysis were derived from five different Finnish genome
scans of complex traits: hypertension (Perola et al. 2000), obesity (study III), familial
combined hyperlipidemia (FCHL) (Pajukanta et al. 1999), osteoarthritis (Leppävuori et
al. 1999) and migraine (Wessman et al. 1998). Altogether, the study material consisted
of 585 individuals from 252 families. Most of the selected families were originally from
the Finnish Twin Cohort (Kaprio 1994), from which the concordant dizygotic twin pairs
were ascertained according to their study criteria. In the case of FCHL, study families
with evidence of dyslipidemia were chosen from the EUFAM study (Pajukanta et al.
1998). All the available parents and additional affected siblings were also collected.
From the osteoarthritis study 94 individuals from 30 families were included in this
combined study, from the obesity study 236 individuals from 87 families, from the
migraine study 108 individuals from 47 families, from the hypertension study 139
individuals from 47 families and from the FCHL study 159 individuals from 41 families.
The demographic details of all study groups are given in Table 6.
All the study subjects from the Finnish Twin Cohort Study had replied to the mailed
health questionnaire of the Finnish Twin Cohort in 1981, 1990 or later, where they were
asked among other questions about their weight and height. In addition to this,
participants in the obesity and FCHL studies were clinically examined in the 1990’s. The
most recent weight, self-reported or measured, was used, the earliest record being from
the year 1990.
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Table 6. Demographic characteristics of the study groups in study IV.
All Obesity Hypertensi
on
Arthrosis Migraine FCHL
number of
individuals
585 185 102 52 87 159
female/male 396/189 122/63 67/35 40/12 78/9 89/70
agea (SD)
range
50.9 (11.6)
 20-85
49.9 (8.9)
21-72
56.7 (9.0)
39-74
58.6 (12.0)
20-80
42.6 (7.1)
32-62
50.3 (14.0)
22-85
BMI (SD)
(kg/m2) range
skewnessb
kurtosisb
29.4 (6.8)
17.4-56.6
0.09
-0.39
36.7 (6.1)
22.3-56.6
0.38
0.37
25.7 (3.1)
18.6-33.5
0.43
0.29
25.9 (4.2)
17.4-39.9
0.29
0.53
24.1 (3.8)
17.4-37.9
-0.25
-0.14
27.3 (3.9)
17.4-37.2
0.73
0.34
Height (SD)
(cm)  range
skewnessb
kurtosisb
166.5 (8.5)
144-194
0.25
-0.24
166.2 (7.7)
144-194
0.26
-0.14
166.1 (8.8)
150-186
0.02
-0.60
166.9 (7.7)
155-186
0.62
-0.07
164.7 (5.8)
151-182
0.48
0.38
167.8 (9.4)
147-191
0.07
-0.48
a individuals under 20 years of age were excluded from the phenotype analyses
b after corrections (1/BMI, square root of height)
2. DNA AND BIOCHEMICAL ANALYSIS
2.1 DNA analysis
2.1.1 Genotyping
DNA was extracted according to standard procedures (Sambrook et al. 1989). In studies
I and II the subjects were genotyped using polymorphic markers within or flanking the
candidate genes and the loci studied. Flanking markers were selected by consulting the
Genome Data Base (at http://gdbwww.gdb.org). Radiation hybrid mapping (Cox et al.
1990) was carried out using the Stanford G3 Radiation Hybrid Panel (Research Genetics,
Huntsville, AL) to clarify the interrelation of polymorphic markers and the MC4-R gene
in the study II. In study III, in the primary genome scan, 374 microsatellite markers
included in the Weber screening set version 6, spaced app. 10.0 cM apart and covering
all 22 autosomes and X chromosome, were genotyped. The estimated average
heterozygosity for the 374 markers was 0.76. In the second stage of the scan, 16
polymorphic markers were additionally analyzed for high-resolution mapping.
The PCRs were carried out with 15-25 µg of DNA in a reaction volume of 15-25 µl
using an MJ Research thermal cycler. In studies I and II, one PCR primer of each pair
was labeled in its 5’ end by (γ-32P) ATP or fluorescein isothiocyanate (FITC). The 32P-
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labeled PCR products were separated by polyacrylamide gel electrophoresis in 6%
denaturing gels. Autoradiography was carried out on Kodak X-Omat films. The FITC-
labeled PCR products were analyzed using an automated laser fluorescence (ALF) DNA-
sequencing instrument (Pharmacia Biotech, Sweden). In study III, forward PCR primer
of each pair was labeled with one of the three fluorescent dyes (FAM, HEX or TET)
(Applied Biosystems, Foster City, CA) to enable detection. PCR products were separated
on an ABI 377XL automated DNA sequencer (Perkin Elmer, Foster City, CA) using
denaturing 6% polyacrylamide gel, with analysis by Applied Biosystems' Genescan 2.1
software (Perkin Elmer). Analysis and assignment of the marker alleles were done
independently by two people with Genotyper 2.0 (Perkin Elmer).
2.1.2 Sequencing
In study III, the potential candidate gene on Xq24 encoding the 5-HT2C receptor was
examined more carefully by association analysis for a known polymorphism, a Cys23Ser
amino acid variant and by sequencing. For assaying the 5-HT2CR polymorphism, PCR
amplification was carried out, and the PCR products were sequenced by cycle-
sequencing using a BigDye Terminator Cycle Sequencing Ready Reaction Kit with
AmpliTaq DNA Polymerase, FS (Perkin Elmer, Foster City, CA, USA) on a model 377
automated DNA sequencer (Applied Biosystems). To confirm the sequencing results of
three subjects, the Thermo Sequenase II dye terminator cycle sequencing premix kit was
also used (Amersham Pharmacia Biotech, Ohio, USA).
2.1.3 Genotyping “in silico”
In study IV, the allele information of five genome scans were standardized by comparing
the allele frequencies of each allele for each analyzed marker, and subsequently
collapsing the alleles from individual scans to the same category based on its frequency.
The reference numbering of alleles was derived from the obesity scan. The data was
obtained from a total of 350 (SD±20) markers per scan.
2.2 Biochemical analysis
2.2.1 Leptin radioimmunoassay
In study I, leptin concentration was determined with radioimmunoassay (Considine et al.
1996), where the intra-assay coefficient of variation was 4.7% and interassay coefficient
of variation was 6.2%.
2.2.2 Measurements of serum glucose, insulin and lipids
In the study I, serum glucose levels were determined by a commercial glucose
dehydrogenase quantification technique (Banauch et al. 1975) and serum insulin levels
were measured by a double-antibody radioimmunoassay (Desbuquois and Aurbach
1971) (Phadeseph Insulin RIA, Pharmacia, Uppsala, Sweden). The levels of total
cholesterol, high-density lipoprotein cholesterol and triglycerides were measured using
enzymatic techniques (Finley et al. 1978) (Boehringer Mannheim).
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3. STATISTICAL ANALYSIS
The computer programs SAS (SAS Institute Inc., Cary, NC) and SYSSTAT (SPSS Inc.,
Chicago, IL) were used to determine sample means, variances and correlations. To test
the equality of means of quantitative traits (leptin levels) by genotype (I), general linear
modeling was used, and for variables that were distributed non-normally (BMI), the
Kruskal-Wallis test was applied (III). The χ2-test was used in association analyses to
compare the frequencies of the different genotypes or categorical variables (I, III). The
differences in markers allele frequency distribution between obese cases and lean
controls were tested by the likelihood ratio test using the DISLAMB program
(Terwilliger 1995) (I).
Prior to tests for linkage, Mendelian segregation was confirmed with PedCheck
(O'Connell and Weeks 1998) (III) and MENDEL (Lange et al. 1988) (IV) programs. All
the incompatibilities in genotypes were either resolved unambiguously or the offending
families were discarded from all analyses. For affected sib-pair analyses in studies I, II
and III, non-parametric allele-sharing methods were used to determine the identical-by-
descent (IBD) status of the pairs. Two program packages were used, ANALYZE
(Kuokkanen et al. 1996; Terwilliger and Göring 2000a) and MAPMAKER/SIBS
(Kruglyak and Lander 1995) to perform two-point and multipoint analyses. The
SIBPAIR program of ANALYZE package, performs pseudomarker linkage analysis. In
sibships of more than two siblings, this algorithm does not break them into pairs, but
rather analyzes them as sibships, which is generally more efficient. The statistic
employed in the SIBPAIR program is computed as a lod score in which all parents are
assumed to be informative for the disease, with all affected sibs inheriting the disease-
predisposing allele from each parent. Estimates of marker allele frequencies were
obtained from the pedigree data by taking the information from parents’ genotypes (II) or
from all individuals (III) using the DOWNFREQ (Göring and Terwilliger 2000c).
In study IV, our traits BMI and height were not normally distributed. Because of the non-
normality, transformations to square root of height and 1/BMI were used in the analyses
because they were found to represent best normal distribution in our sample. Age was set
to represent the year of reported or measured weight or height when used as a covariant
in the analyses. The linkage analyses were done using the Solar 1.625 program (Almasy
and Blangero 1998; Blangero and Almasy 1997) and MAPMAKER/SIBS version 2.0
(Kruglyak and Lander 1995), with the ML variance option (Pratt et al. 2000) in the case
of X-chromosomal markers. Since individuals with BMI ≥ 30.0 kg/m2 originating from
the obesity study and ≤ 27.0 kg/m2 originating from the hypertension study were
originally selected according to their BMI, they were labeled as probands in Solar
analyses to ascertainment bias correction.
To evaluate the significance of our results, we permuted the phenotype values (age, sex,
stature) randomly for 100 times and re-calculated the genome scans using these
permuted phenotype values. In the permuted scans the same adjustments for covariates
age and sex were used as in the original scan. We permuted rather phenotypes than
genotypes because not all individuals were genotyped for all the markers.
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RESULTS
1. ANALYSES OF CANDIDATE GENES AND REGIONS
1.1 Leptin
The leptin (OB) gene was the first candidate gene studied in this thesis, and its role in
obesity was evaluated using different approaches. Genetic linkage and association were
tested between obesity and polymorphic markers flanking the leptin gene (D7S686,
D7S514, D7S635, D7S530, D7S680, D7S1875, HOB) in sib pair and case-control
materials (I). No significant evidence for linkage to obesity was found in 76 concordant
sib pairs (BMI ≥ 32 kg/m2), neither was association found with 252 morbidly obese
cases (BMI ≥ 40 kg/m2) and 151 lean controls.
The correlations between serum leptin levels and BMI as well as marker alleles were
studied in case-control material. A significant positive correlation was found in men
(p=0.0001) and in women (p=0.0001) between leptin concentration and body-mass index
(I). To date, this is quite an obvious result if we view leptin as hormone secreted by
adipose tissue. Although there are individual variations, in principle, the more fat the
more leptin is secreted in the circulation (Considine et al. 1996). When serum leptin
levels were analyzed according to flanking markers, only the marker D7S530 was
associated (p=0.04): more spesifically, allele 5 was associated with lower leptin levels
(p=0.02) and allele 7 was associated with higher serum leptin levels (p=0.02). However,
when the carrier status of these alleles was tested with BMI of the obese subjects, no
association could be seen. Further, the leptin concentrations did not correlate with serum
cholesterol, HDL-cholesterol or triglycerides, nor with serum glucose or insulin levels.
1.2 Other candidate genes
In study II, linkage between obesity and human homologues of seven murine obesity
genes, one claimed “anti-obesity” murine gene and two loci, D2S1788 and D11S900,
reported to be linked to obesity related phenotypes in restricted populations (Comuzzie
et al. 1997; Norman et al. 1997), was tested. A total of 105 sib pairs were genotyped and
analyzed for 30 polymorphic markers flanking the candidate regions. No significant
evidence of linkage was detected in two-point analyses with any of the markers.
However, several markers spanning a region of 14 cM, and lying in the immediate
vicinity of the MC4-R gene, indicated excess sharing of the alleles IBD (Figure 5).
Further, marker D11S1321 flanking UCP2 and UCP3 genes showed some evidence of
increased allele-sharing (p=0.011) as well as marker D1S250 flanking the OB-R gene
(p=0.054). Other markers in these chromosomal regions revealed no evidence for
linkage. Two-point results of all the analyzed markers are given in Figure Y.
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Based on the findings of two previously reported genome scans (Comuzzie et al. 1997;
Norman et al. 1997), chromosomal regions 11q21-q22 and 2q21 were investigated, but
no linkage between morbid obesity and the selected markers (D11S900, D2S1788) was
found. However, we tested only for linkage with the final phenotype of obesity (BMI ≥
32 kg/m2) and not with specific quantitative phenotypes, such as % body fat or serum
leptin levels.
Figure 5. The p-values obtained from two-point linkage analyses between obesity and markers within and
flanking the candidate genes in sib pair material. All the p-values over 0.05 were considered nonsignificant
(NS) and were excluded from further analyses. The length of different regions is indicated by
centimorgans (cM) (web sites: http://www-genome.wi.mit.edu and http://cedar.genetics.soton.ac.uk/
public_html/index.html). *These markers flanking the OB gene were analyzed previously in study I.
To further increase genetic homogeneity and to dissect the clinical phenotypes, the study
sample of 105 sib pairs was divided into five different subsets. The first and second
subsets were composed of sib pairs having both parents originating either from the
eastern or southwestern regions of Finland, respectively. The rationale for this was based
on the well-demonstrated difference of risk factors for cardiovascular diseases between
eastern and southwestern Finland (Vartiainen et al. 1994). The third group was selected
to represent severe obesity having an inclusion criteria of BMI ≥ 37 kg/m2 for all siblings
in a sibship. In the fourth subgroup all diabetic individuals, defined on the basis of
current medication for diabetes, were excluded. In the fifth subgroup only sib pairs
having one lean (BMI ≤ 26 kg/m2) and one obese (BMI ≥ 32 kg/m2) parent were
accepted. The number of sib pairs in these individual subsets, are given in Table 7.
OB-R OB TUB
MC4-R
D1S515 NS D7S680 NS* D11S932 NS
D18S851 0.014
D1S250 NS HOB 0.048 7 cM D11S1999 NS
2 cM D18S487 0.005
D1S2852 NS D7S1875 NS* D11S902 NS
3 cM D18S69 NS
OBR-CA NS D7S530 NS*
D18S858 0.009
OBR-CTTT NS
17 cM D18S849 0.024
D1S2825 NS UCP2 and UCP3
D18S1129 NS
D1S198 NS D11S916 NS
PRKAR2B D18S1155 0.010
D11S1291 NS
ASP D7S658 NS 9 cM D18S64 0.013
8 cM D11S1321 0.011
D20S200 NS D7S496 NS D18S38 0.044
D11S911 NS
6 cM D20S106 NS D18S1148 NS
D20S107 NS
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Table 7. The p-values obtained from two-point analyses between obesity and markers of interest
(D18S851, D18S487, D18S69, D18S858, D18S849, D18S1129, D18S1155, D18S64, D18S38)
flanking the MC4-R gene and covering a region of 14 cM (http://www-genome.wi.mit.edu) in
total material and different subgroups.
Two-point analyses in different subgroups showed further evidence for linkage to
markers D11S1321, D1S250 and markers flanking the MC4-R gene on chromosome 18.
The subgroup from which all the diabetic subjects had been excluded revealed the
strongest evidence for linkage between several MC4-R gene markers and obesity.
However, the smallest p-value (p=0.001) was obtained with the marker D18S849 in a
subset containing only sib pairs that had one lean and one obese parent (Table 2).
Being the most interesting candidate, the MC4-R gene was further examined by DNA
sequencing. The coding, as well as 5'- and 3'- flanking regions were sequenced in seven
obese subjects, belonging to the sib pair material. A single base substitution replacing, as
judged from the published sequence (Mountjoy et al. 1994), valine (GTC) for isoleucine
(ATC) at codon 103, was identified. All seven individuals were homozygous for the
valine allele, and no carriers of the isoleucine allele were detected. Furthermore, at
codon 169, where Mountjoy et al. (1994) reported sequence for serine (AGC), all the
cases had a sequence corresponding to isoleucine (ATC). Also, one additional adenine
nucleotide was found in the 3'-flanking region in all the obese subjects between
nucleotides 1114 (A) and 1115 (T). All these sequence variations found in Finnish obese
subjects had been previously identified in white British males (Gotoda 1997).
N S851 S487 S69 S858 S849 S1129 S1155 S64 S38
Total material 105 0.014 0.005 0.184 0.009 0.024 0.440 0.010 0.013 0.044
Parents originating
from eastern
Finland
38 0.051 0.048 0.159 0.022 0.062 0.500 0.092 0.373 0.239
Parents originating
from western
Finland
51 0.358 0.093 0.500 0.500 0.247 0.488 0.177 0.017 0.100
BMI ≥ 37 kg/m2
for each sib,
“severe” obesity
39 0.236 0.013 0.056 0.024 0.076 0.500 0.235 0.049 0.500
Sibs having
medication for
diabetes excluded
80 0.004 0.006 0.061 0.008 0.003 0.322 0.014 0.012 0.017
One parent having
BMI ≤ 26 kg/m2,
the other BMI ≥ 32
kg/m2
20 0.074 0.001 0.072 0.020 0.006 0.482 0.129 0.074 0.093
* N. means the number of sib pairs in each of the subgroups
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1.3 Three stage genome-wide scan
To search for novel loci predisposing to obesity in the Finnish population, a genome-
wide screening was performed (III). At this time, five previous obesity scans had been
published from other populations (Comuzzie et al. 1997; Hager et al. 1998; Hanson et al.
1998; Lee et al. 1999; Norman et al. 1997). Therefore, it was of interest also to see,
whether those findings could be replicated in the genetically isolated Finnish population.
 The genome scan of obesity (defined as a BMI ≥ 32 kg/m2) was carried out in three
stages with initially 100 sib pairs (altogether 188 affected) from 87 families. In the first
stage, two-point analyses of the 374 scan markers revealed nine regions with marginal
evidence for linkage (MLS >0.8) on chromosomes 1q, 4q, 5p, 9p, 10q, 12q, 16q, 18q
and Xq (Table 8). Generally, the multipoint ML scores tended to be lower than the
values for two-point MLS. The most significant evidence for linkage was found on
chromosome Xq, with the marker DXS8064 giving a two-point MLS of 3.14. The
highest multipoint values were established on chromosomes 18q and Xq, where the
MLS reached 2.16 and 2.10, respectively. In addition, multipoint MLSs >1.0 were found
on chromosomes 1, 5, 10, 11 and 12.
In the second stage, to increase the phase information, 16 screening set markers were
genotyped on the positive regions showing two-point MLS >0.8, with all the available
parents. This resulted in an increase of ML scores on chromosomes 1q, 4q, 12q and 16q,
whereas the ML scores decreased or did not change on chromosomes 5p, 9p, 10q and Xq
(presented in Table 8).
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Table 8. Single-point maximum likelihood scores (MLS) of markers revealing marginal
evidence for linkage, MLS of markers after genotyping the parents, parametric LOD scores and
markers chosen for saturation mapping are indicated (*data also published in Study II).
For the fine-mapping, we selected six regions on chromosomes 1q, 4q, 5p, 12q, 18q and
Xq that provided two-point MLS >1.0. We performed genotyping using 24 additional
markers on these regions in our initial study material of 188 individuals (100 sib pairs).
The saturation mapping supported evidence for linkage only on chromosomes 18q and
Xq (Table 9). On the other regions, all the obtained ML scores remained <1.0.
For the third stage of the scan, a replication material of 171 obese (BMI ≥ 30 kg/m2)
individuals (93 sib pairs) from 79 families, were ascertained. Selecting the markers with
the best evidence for linkage, five markers on chromosome 18q21, and five markers on
Marker MLS > 0.8 MLS with
parents
genotyped
Parametric
LOD scores
Saturation
mapping
D1S518 1.08 1.44 1.37 x
D4S2368 1.19 1.37 0.62 x
D5S1470 1.19 1.07 1.00 x
D5S1501 1.04 0.74 0.75 x
D5S1462 0.87 0.87
D5S1456 1.17 1.11 0.76 x
D9S921 0.93 0.00
D9S1118 1.18 1.16 0.73
D9S158 1.01 0.87 0.64
D10S1223 0.93 1.06
D10S169 1.25 0.89 0.73
D11S2002 0.86 0.35
D12S2070 1.08 1.17 0.46 x
D12S395 1.26 1.32 1.86 x
D16S3110 0.84 1.26 1.01
D18S851 1.62 0.86 x
D18S487* 1.97 1.87
D18S858 0.83 0.98
D18S1155* 1.82 0.70
D18S64 1.61 1.59 0.98 x
D18S38* 0.80 0.43
DXS6800 0.85 0.76 0.50
DXS6799 1.20 1.16 0.36 x
DXS6804 3.14 2.96 1.60 x
DXS1001 1.21 1.41 0.00 x
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Xq24 were genotyped. Allelic data for the replication sample set was analyzed separately
as well as in pooled analysis with the original study material. The replication material
alone provided additional evidence for linkage on the Xq24 region as the two-point MLS
of DXS8067 was increased from 0.6 to 2.5. The two-point MLS for other reanalyzed
markers did not change significantly. In the pooled analysis of 193 sib pairs, two-point
ML scores further increased on the Xq24 region: the MLS of DXS8067 increased to 2.7
and that of DXS1001 to 2.2 (Table 4), and the multipoint MLS reached a significant
value of 3.5 (Fig. 6).
Figure 6. Two-point (represented as bands) and multipoint (line) ML scores over the Xq24 region in the
extended material in the third stage of the genome scan.
None of the 18q region markers showed strong evidence for linkage in the replication
material, the highest two-point MLS being 0.9 with marker D18S487. However, the
pooled analysis including 193 sib pairs strengthened the linkage to 18q2: the two-point
MLS of D18S1155 increased from 1.8 to 2.4 and that of D18S64 from 1.6 to 2.3 (Table
9). The multipoint MLS values did not exceed the significance level in this genomic
region.
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Table 9. Data from three stages of the genome scan. Two-point ML scores obtained with the
markers on chromosomes 18q21 and Xq24 providing the strongest evidence for linkage.
1.3.1 Serotonin receptor 2C
On the Xq24 region, the most potential candidate gene, 5-HT2C  receptor (Nonogaki et
al. 1998), was selected to be examined more carefully by association analysis and DNA
sequencing. A previously reported polymorphism of this gene, a Cys23Ser amino acid
variant (Lappalainen et al. 1995) was examined to test for differences in allelic
frequencies conditional on phenotype. This polymorphism was genotyped in an
association material of 254 morbidly obese subjects and 134 lean controls. The genotype
and allelic frequencies did not differ between the study subjects and the controls (p=0.42
for females, p=0.96 for males).
To further study the 5-HT2CR gene for sequence changes, 18 obese males and 19 lean
male controls were screened. The coding region and the known promoter region of 7.3
kb (Xie et al. 1996) were sequenced, but no DNA-variants correlating with obesity were
found. In exon 3, a single-nucleotide polymorphism (C→A) -42 bp upstream of the 5’-
end of the coding region was identified in one obese male and the previously published
(G→C) polymorphism in codon 23 (Cys23Ser) was detected in another case. In the
promoter region, two polymorphisms that were present in three cases and six controls
were found: a C→T variation at position -757 and a G→C variation at position -690. In
addition, we found two single-nucleotide insertions in all cases and all the controls:
compared to the published sequence, there was one additional guanine (G) in position -
815 and another G in position -870 upstream of the 5’-end of exon 1.
1.4 QTL analysis of body-mass index and stature
In study IV, analyses were carried out on total study material as well as on males and
females only. Since the sex-specific results did not differ significantly from the results of
the total study sample, only the age- and sex adjusted results were reported. Further, only
Marker Initial genome
scan
Fine-mapping Extended study
material
DXS6799 1.20 1.16 1.08
DXS6804 3.14 2.96 2.96
DXS8064 0.96 0.49
DXS8067 0.63 2.73
DXS1001 1.21 1.14 2.17
D18S851 1.62 1.39 0.29
D18S487 1.97 1.84
D18S858 0.92 0.92 0.27
D18S1155 1.82 2.42
D18S64 1.61 1.59 2.32
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the multipoint results were given with no two-point lod scores, since not all of the
markers were analyzed in all of the scans.
1.4.1 Body-mass index
The heritability of BMI in the study sample was found to be 0.49. Sex (p=0.03) and age
× sex (p=0.01) were significantly correlated with BMI and thus were included in the
final model. The highest multipoint lod score for BMI was found in chromosome 5,
peaking at 1.54, 54 cM from p-ter. No other chromosome showed lod scores ≥1 for BMI
in the multipoint analysis.
1.4.2 Stature
The heritability of stature in total study sample was found to be 0.70. This corresponds
well to a recent study of heritability of height in the Finnish population, where
heritability was 0.77 (95% CI=0.73, 0.82) among men and 0.76 (95% CI=0.71, 0.80)
among women (Silventoinen et al. 2000). Sex (p<0.0000001) and age (p=0.04) were
significantly correlated with stature and thus they were included in the final model. The
highest multipoint lod score was recorded in chromosome 18q, peaking at 3.01, 74 cM
from the pter at the location of marker D18S858 flanking the MC4-R gene (Figure 7).
Also, in chromosome 7 a lod score of 2.82 was found 163-164 cM from pter. The only
other chromosome with a lod score over 2 was 12, where a lod score of 2.26 was
obtained at 65 cM from pter. No clear candidate genes influencing stature have yet been
located in the regions of chromosome 7 and 12, although both of the regions are quite
wide. In the multipoint analyses, no other chromosomes showed any significant evidence
for linkage to stature.
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Figure 7. The multipoint lod score curve on chromosome 18 in the QTL analysis of stature. The
highest lod score peaks at 3.01. The used chromosome 18 markers are shown on the x-axis.
To assess the statistical significance of our results, we performed simulations. In the 100
permutated genome scans, we found the multipoint lod score > 3.01 a total of five times,
giving an empiric p-value 0.05. Lod scores of over 2.82 were seen seven times (p=0.07)
and 2.26 thirty-six times (p=0.36). No permuted genome scan showed a combination of
three or more lod scores > 2.26 (p<0.01).
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DISCUSSION
1. PHENOTYPE OF OBESITY – OBESE STUDY SUBJECTS
In genetic studies of complex diseases, fairly large sample sizes are needed to detect
common alleles of slightly modifying effects from the “noise” of environment. Enough
power is essential even if genetically isolated populations are used (Terwilliger et al.
1998). Additionally, careful dissection of phenotype and subgrouping of the sample set
give a better chance to detect several loci of a small effect than a group of study subjects
robustly tied together with loose criteria presenting the same diagnosis. In fact, most of
the complex diseases could probably be allocated to several subclasses or variables of
the “mother disease”: for instance, in case of schizophrenia or migraine, patients with the
same diagnosis do not necessarily have the same symptoms, and according to the clinical
picture, they represent several subclasses of the disease. In quantitative traits,
categorization can be made by setting cut-points to the continuous variable, e.g. mild or
severe hypertension based on the selected blood pressure values.
In genetic studies of obesity, a tendency towards refining the phenotype has been clear.
To dissect the phenotypic picture of obesity, much more should be done than just
obtaining a certain cut-off point of body-mass index to measure morbid obesity. Several
aspects have been taken into account, e.g. behavioral (binge eating), age-of-onset
(childhood obesity), related diseases (NIDDM, endocrinological derangement),
proportions of fat-mass and fat-free mass, respiratory quotient (to measure basal
metabolic rate), plasma levels of secreted proteins (leptin), physical activity and the
waist-to-hip ratio (Bouchard et al. 1988; Chagnon et al. 1997; Comuzzie et al. 1997).
The genetic background has also been utilized to homogenize the study group (Norman
et al. 1997; Rotimi et al. 1999).
In this study (I, II, III) the phenotype of obesity was based solely on the selected BMI
cut-off point: the first recruited probands from the weight reduction group, the morbidly
obese subjects, had had BMI ≥ 40 kg/m2, and their ascertained siblings BMI ≥ 32 kg/m2.
For the replication sample set (III) the criteria was BMI ≥ 30 kg/m2. The leptin levels
were measured only from the morbidly obese cases (n=252) from the weight reduction
group (I). Presumably, it would have been advantageous to refine the phenotype by
measures of, for instance, body composition or basal metabolic rate, since BMI provides
only an indirect measure of fatness and is not the most accurate indicator of obesity
(Borecki et al. 1991). However, the morbidly obese cases represent the extreme end of
the phenotype, and could be useful to increase the heritable component of the disease
(Lander and Kruglyak 1995). Approximately half of the recruited sib pairs were
dizygotic (DZ) twins ascertained from the Finnish Twin Cohort. DZ twin pairs represent
ideal study material for sibling pair analyses, for they are perfectly matched for age and
closely matched for many pre- and post-natal environmental factors (Martin et al. 1997).
The size of the sib pair study sample was limited, when compared to other genetic
studies of obesity (Chagnon et al. 1997; Comuzzie et al. 2000; Norman et al. 1996).
However, the advantage of using the homogeneous and genetically isolated Finnish
population has been proved by excellent examples of identification of loci predisposing
to complex diseases, even with small sample sizes (Kainulainen et al. 1999; Kuokkanen
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et al. 1996; Leppävuori et al. 1999; Perola et al. 2000).
In study II, a subgrouping of the sample set, based on different perspectives, was used.
First, the geographical origin of the proband’s parents was implied – the rationale for
this was derived from the well-demonstrated difference in risk factors for cardiovascular
diseases between eastern and southwestern Finland (Kittles et al. 1998; Vartiainen et al.
1994). Second, only pairs where both represented severe obesity (BMI ≥ 37 kg/m2) were
included. Third, the idea was to exclude diabetic subjects, and thus remove confounding
factors such as co-morbidities. The last group was reasoned to represent a clearer mode
of inheritance, i.e. predisposing allele descending from one side only: thus, only those
pairs, where one parent was obese (BMI ≥ 32 kg/m2) and the other lean (BMI ≤ 26
kg/m2), were selected. The division of the study sample into subclasses was found to be
advantageous, since more significant p-values were obtained with the MC4-R flanking
markers in the group of non-diabetic (p=0.003) and in the group that imitated the
“dominant inheritance model” (p=0.001).
For the sequencing analysis of MC4-R and 5HT2CR (II, III) only a few study subjects
were used. To search for sequence variations in MC4-R, nine obese cases were screened,
and for 5HT2CR, 19 cases and 18 controls were analyzed. Recently, it has been
suggested that among the morbidly obese subjects, 3-4% carry an obesity causing
mutation in their MC4-R gene (Vaisse et al. 2000), and thus far, these would represent
the most frequent mutations causing dominantly inherited human obesity. In view of
this, it is no wonder, that our study failed to demonstrate any obesity associated DNA
variants from the tiny sample set: to catch one mutation among these seven cases, the
probability would be around 25%. However, we did find DNA variants that had been
previously identified in Caucasian populations (Gotoda et al. 1997) in the MC4-R gene,
but evidently these were conservative polymorphisms not altering the coding region.
Sequencing of the 5HT2CR revealed a previously published amino acid variation
(Lappalainen et al. 1995), but this was not associated with obesity in our study, although
it has been implicated in eating disorders (Burnet et al. 1999). However, in our analysis
we used only the simple phenotype of obesity, any behavioral aspects concerning the
aetiology of obesity were not considered.
In study IV, the quantitative trait loci of body-mass index and height were searched for
in the Finnish population by combined analysis of five genome scans. Using the 1/BMI
and the square root of height as variants normalized the distribution of these continuous
phenotypes. Convincing linkage to two loci affecting stature were identified in our study
material, but no linkage was detected to BMI. This may reflect the difference between
these two continuous variables, e.g. the extent of confounding factors affecting their
outcome. The height of adults is usually attained during the puberty, and it remains
essentially the same throughout life, whereas BMI may vary considerably during an
individual’s lifetime. In other words, there are far more environmental factors affecting
BMI than stature in adult age, and one occasional measurement of weight at one
occasional moment of time is naturally less characteristic for a person than his or her
height. Further, as it has been shown, the use of extreme concordant or discordant pairs
could yield much more significant results in QTL analysis than the use of such pairs that
represent both mean values of a continuous variable (Risch and Zhang 1995). So far, no
studies have been reported, where QTL affecting body weight has been found with
normal weight human subjects.
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Furthermore, in our study material, the heritability of stature was higher than that of the
BMI (0.70 vs. 0.49). This may, in part, explain why linkage was detected for stature but
not for BMI. It has been reported, that extreme obesity is more heritable than moderate
overweight, i.e. the familial risk ratio for extreme obesity is higher than for moderate
levels of obesity (Lee et al. 1997). Thus, the number of families or relative pairs required
to achieve adequate statistical power in gene mapping studies of obesity can be reduced
substantially by focusing on family members of extremely obese individuals (BMI ≥ 40
kg/m2). Furthermore, Allison et al. (Allison et al. 1996) investigated the λ statistics in
obesity, and concluded that λs for milder forms of obesity were disappointingly low.
Therefore, an impractically large number of sib pairs would be necessary to reach a
sufficient power to detect linkage for obesity related genes. Since our study population
consisted mainly of normal weight subjects, the current methods as well as the size of
the study sample may prove insufficient to detect a locus affecting the relative body
weight, i.e. BMI, especially if this sort of locus has only a minor genetic effect.
2. LINKAGE TO OBESITY - SUGGESTIVE OR SIGNIFICANT
In study I, the marker D7S530 was found to be associated with variations of serum leptin
levels in morbidly obese subjects. This particular marker showed the strongest evidence
for linkage to obesity in a study of French sib pairs (Clement et al. 1996), but in our
study (I, II), no association or linkage between D7S530 and obesity per se could be seen.
Based on the most recent genome scan for loci linked to plasma leptin levels, it has been
suggested that the genetic determinants of leptin concentration and BMI are, to some
extent, distinct (Walder et al. 2000), because no chromosomal region demonstrated
evidence of linkage with both BMI and plasma leptin levels. Although several markers
flanking the ob gene have shown suggestive linkage to obesity in some populations
(Clement et al. 1996; Reed et al. 1996), contradictory data has been presented by others
(Hasstedt et al. 1997; Norman et al. 1996; Stirling et al. 1995). Our study showed no
evidence for linkage, or association of any ob gene markers to obesity in the Finnish
population (I, II). Our finding is in agreement with the view that obesity-causing
mutations in the ob gene are extremely rare in human subjects (Considine et al. 1995;
Maffei et al. 1996).
According to the Human Obesity Gene Map, an extensive annual review gathering data
from all reports concerning the genetic studies of obesity (Chagnon et al. 2000), putative
loci affecting obesity-related phenotypes are found on all but the Y chromosome of the
human chromosomes. The number of genes and other markers associated or linked with
human obesity phenotypes continues to grow and is now well over 200. Results of
linkage and association studies of human homologues of murine obesity genes from
different populations have been conflicting. The reasons for this could include different
ethnic backgrounds, criteria for patient selection and the variety of phenotypes analyzed.
Eventually, some of these findings will turn out be to false-positives whereas some of
them will certainly prove to be replicable and thus more important than others.
Initially, no evidence for significant linkage to any candidate gene was detected in study
II. The sample size of our sib pair material was initially quite small and divisions to
subsets further decreased it (II). In non-parametric linkage analysis, very restricted
sample sizes lead to the power of the study to decrease, and also to an increased chance
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of type 1 errors. However, given the p-values were not highly significant, excess IBD
sharing was observed in elongated, 14 cM region flanking the MC4-R. A study which
shows that relatively wide peaks could represent a reliable linkage compared to narrower
peaks (Terwilliger et al. 1997), strengthens our finding of suggestive linkage to MC4-R.
Considering the MC4-R finding in the genome-wide context (III), further support for the
result of our candidate gene study may be derived. In the genome screen, the second
most significant evidence for linkage came from markers flanking the MC4-R gene, i.e.,
a two-point maximum-likelihood score of 2.42 for marker D18S1155 in the extended sib
pair material. The significance level of this MLS corresponds relatively well to our best
p-values in the candidate gene analysis (p=0.001). Looking retrospectively, it is of great
interest, that the subset of sib pairs representing “dominantly inherited obesity” (one lean
parent and one obese parent), gave the most significant p-value in study II. At the time of
this study, it was not known that the MC4-R mutations cause dominantly inherited
human obesity, nor was it proposed that these mutations are such a frequent (3-4%)
contributor to human morbid obesity (Farooqi et al. 2000; Vaisse et al. 2000).
3. GENOME SCANNING AND BEYOND
In genome-wide searches completed in other populations, evidence for linkage of
different obesity-related phenotypes has been reported to several loci on different
chromosomes (Table 10) (Comuzzie et al. 1997; Hager et al. 1998; Hanson et al. 1998;
Lee et al. 1999; Norman et al. 1997; Walder et al. 2000). None of the earlier screens
have reported a significant linkage to the X-chromosome. However, supportive data for
our finding was derived from the genome screen of French obese sib pairs (Hager et al.
1998) where some evidence for linkage was reported to the same chromosomal region
Xq24 (multipoint MLS 1.42 with DXS1001). Additionally, they found a suggestive
linkage to Xp (multipoint MLS of 2.42 with DXS1226). Even if we did not detect
significant linkage to the same regions as the previous genome scans, our results do not
exclude any earlier findings: those loci just do not seem to be the major determinants of
obesity in the Finnish population. The detection of loci with modest effects would most
probably require a much larger sample size than was available in our study (Allison et al.
1996). The inconsistent findings across the different scans certainly reflect differences in
ascertainment of study subjects, definition of phenotypes as well as variability in genetic
background.
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Table 10. The most significant quantitative trait loci, the nearest markers and the most significant lod
scores obtained in genome scans of obesity and related traits in other populations. Modified from Chagnon
et al. (2000).
Marker Location Phenotype* N sib pairs Lod score Ref.
D1S550 1p31-p21 24 h RQ 236 2.0 Norman 98
D2S1788 2p21 Leptin,
Fat mass
>5000 rela-
tive pairs
4.5
2.8
Comuzzie 97
D2S165,
D2S367
2p22-p21 Leptin 264 2.4 / 2.7 Hager 98
D5S426 5p11 Leptin 264 2.9 Hager 98
D6S271 6p12-21 Leptin 1199 2.1 Walder 2000
D8S1110 8q11.1 Leptin >5000 rela-
tive pairs
2.2 Comuzzie 97
D10S197 10p12.3 Obesity 264 4.9 Hager 98
D11S2000,
D11S2366
11q21-q22 %fat 277 2.8 Norman 97
D11S2366 11q22 %fat 451 2.1 Norman 98
D11S976 11q23-q24 24h EE 236 2.0 Norman 98
D11S912 11q24 BMI 1766 3.6 Hanson 98
D18S877 18q21 %fat,  FFM 451 2.3 Norman 98
D20S107,
D20S211,
D20S149
20q13 BMI>30,
% fat
423 3.0<
Lod
<3.2
Lee 99
D20S601 20q11.2 24h RQ 236 3.0 Norman 98
* EE= energy expenditure; F = skinfold; FFM = fat free mass; RQ=respiratory quotient; BMI=body mass
index; RMR=resting metabolic rate; WHR=Waist to hip circumferences ratio.
Pertaining to our results, there was some overlap in positive regions with genome-scan
by Lee et al. (1999): on chromosome 1, our marker D1S518 (location 204 cM from p-
ter) giving two-point MLS 1.4 corresponds to their D1S194 (206 cM) with a p-value of
0.0126 for percentage of fat (%fat). This region on 1q21-23 is homologous with pig and
mouse obesity QTLs (Andersson et al. 1994; Taylor and Phillips 1996). On chromosome
9, our D9S158 (158 cM) with two-point MLS 1.0 is near their D9S1863 (151 cM) with a
p-value of 0.185 for BMI. On chromosome 10, our D10S1223 (160 cM) and D10S169
(171 cM) with two-point MLSs 0.9 and 1.3 respectively, are in concordance with their
D10S587 (170 cM) with a p-value of 0.0113 to %fat.
On the MC4-R region on 18q, our results in the genome-wide scan support the positive
findings of our candidate gene study (II) showing the same level of significance. A novel
important finding is that our results suggest that a major locus affecting the obesity
phenotype lies on chromosome Xq24. An X-chromosomal obesity gene would be
consistent with the fact of sex-specific effects on BMI: sex differences exist between
obesity phenotypes, for instance abdominal obesity is more prevalent in males (Dionne
et al. 1999; Kissebah and Krakower 1994), and it has been indicated in twin studies that
genes contributing to the variation in BMI are not identical for men and women (Harris
et al. 1995; Pietiläinen et al. 1999). Our interest on the Xq24 region focused on a
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candidate gene, serotonin receptor -2C (5HT2CR), which had been widely implicated in
body weight regulation in humans (Heisler et al. 1998; Leibowitz and Alexander 1998;
Sargent et al. 1997) and in mice (Nonogaki et al. 1998). In addition, several other
functionally relevant candidate genes have been assigned to our region of interest, for
example the fibroblast growth factor homologous factor 2 (FHF2) (Gecz et al.
1999), the NDUFA1 gene, which is a component of NADH:ubiquinone oxidoreductase
in mitochondrial complex I (Zhuchenko et al. 1996), and the brain mitochondrial
carrier protein-1 (BMCP1) (Sanchis et al. 1998).
The involvement of 5HT2CR was investigated first with an association analysis, which
was performed with a known amino acid substitution (Lappalainen et al. 1995), and
secondly, by sequencing the coding and promoter region of 7.3 kb. No association or
obesity-associated DNA-variants were found. The results are in agreement with a similar
study (Lentes et al. 1997) which found no evidence for association of this polymorphism
with obesity. However, it could have been revealing to sequence the promotor region
with a larger set of samples, since a Japanese study found several nucleotide
substitutions in the 5’-promoter region (Yuan et al. 2000). The constructed haplotypes
were associated with either obesity or non-obese non-diabetic status.
In study IV, a combined QTL analysis of five genome scans was performed to identify
new loci affecting body weight. By pooling raw data from multiple data sets, our study
represents a novel aspect in meta-analytic approaches. In epidemiology, conventional
approach is to rather pool summary statistics than genotype data (Allison and Heo
1998b; Gu et al. 1999b; Li and Rao 1996).
In addition to BMI, we selected body height as a continuous variable, since it affects the
value of relative body-mass. Further, with the study of Hirschhorn et al. (Hirschhorn et
al. 2001 submitted) this study represents the first reported genome-wide scan of stature.
A suggestive linkage between stature and chromosome 18q was found. The highest
multipoint lod score (3.01) was obtained with marker D18S858 flanking the
melanocortin –4 receptor  gene (MC4-R). It is of interest, that in addition to being obese,
the human subjects with MC4-R mutations are also tall and have an increased bone
mineral density (Farooqi et al. 2000; Yeo et al. 2000). In other species such as pigs and
mice, the MC4-R mutations affect growth and increase body length (Huszar et al. 1997;
Kim et al. 2000). Since both obesity and short stature have been shown to be risk factors
for coronary heart disease (Eckel 1997; Forsen et al. 2000), this raises a tantalizing
question whether MC4-R could be a susceptibility gene behind these two risk factors.
Furthermore, an earlier genome scan of Finnish families with early-onset coronary heart
disease reported evidence of linkage to a marker GATA26C03 only 20 cM from our
area, the multipoint lod score peaking at 1.68 and two-point lod score peaking at 2.12
(Pajukanta et al. 2000). As the multipoint lod score method does not necessarily peak at
the exact spot of the underlying disease gene (Kruglyak and Lander 1995), it is not
impossible that a gene in this region could be a candidate for all these traits.
The second piece of suggestive evidence for linkage to body height was found at
chromosome 7qter with a multipoint lod score of 2.82. The relevance of this finding is
emphasized by the results of Hirschhorn et al. (Hirschhorn et al. 2001 submitted)
replicating this very same region in their Swedish population (multipoint LOD = 3.40).
Further, their Finnish sample set from the population of Helsinki shows some additional
evidence of linkage with a lod score of 1.7 close to the qter of chromosome 7. Yet
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another overlapping region between these two studies is on chromosome 12q, where
Hirschhorn et al. report evidence for linkage (multipoint LOD =  3.35) with their Finnish
subgroup from Helsinki in the very same region as us. Since both chromosomal intervals
on 7qter and 12q are quite wide, no clear positional candidate genes can be speculated
on.
Our novel meta-analytic approach of combining genome scans produced convincing
results in the QTL analysis of stature, but the results concerning BMI remained very
modest. However, this work should be taken as a proof-of-principle of new possibilities
arising from the use of the enormous amount of data generated by several genome scan
studies. In a pooled meta-analysis of multiple data sets one could choose between
pooling of raw data or summary statistics. The putative problems of this novel approach
include the ascertainment bias of study material, the heterogeneity of sample sets and
ethical issues. Combining subjects that are originally selected on the basis of very
different criteria may represent a too heterogeneous sample set. Thus, certain phenotypic
characteristics might be unsuitable for a QTL study, for which samples of the extreme
ends of trait may be the most advantageous ones (Risch and Zhang 1995). Ethical
aspects should not be neglected when analyzing such phenotypic or clinical data that
were not originally intended to be used for such research. An informed consent of
participants is naturally required for each additional study apart from the original one,
and lack of the consent would most probably be the greatest problem hindering the use
of this novel approach. However, if this is taken care of, using all the collected data is
highly justified from both economical and ecological point of views.
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CONCLUDING REMARKS AND FUTURE PROSPECTS
Ever since the genetic studies of single gene Mendelian disorders have become
undemanding and quite simple methodologically, the studies of complex diseases have
attracted the increasing interest of geneticists. The rate in determining disease genes will
certainly be accelarated due to the publication of the human genome sequence
(Consortium 2001; Venter et al. 2001). Today, more and more studies of the common
multifactorial traits are carried out, in attemps to find genes and alleles that contribute to
the development of polygenic and environmentally influenced phenotype. The design of
new technical tools to advance these large-scale studies has been so rapid that the
development of new statistical tools has been following one step behind. This trend
seems to continue as the society of geneticists is eagerly moving from the “old” linkage
studies with microsatellite markers to the “new” linkage disequilibrium studies with
single-nucleotide polymorphisms (SNPs). Multiplex expression array studies will also
provide new implements in studies of complex diseases. One of the most powerful
methods to investigate complex diseases is animal models. They provide enormous
amounts of important new knowledge of disease pathogenesis, development of
phenotypic picture and the role of putative candidate genes in a particular disorder. The
“purification” of the genetic background is simpler with animal strains and thus, subtle
effects are seen more easily in animals than in human subjects.
Today, the task of finding common allelic variants of marginal genetic effect on
phenotype is very demanding work requiring a lot of resources. The enthusiastic belief
that the minor effects of susceptibility alleles would account for a substantial proportion
of the population risk for common diseases in a clear predictive way, may turn out to be
largely exaggerated (Weiss and Terwilliger 2000). The proportions of the environmental
impact and heritability are still hard to assess, although twin and adoption studies have
offered some estimates. It remains to be seen on which scale all the collected knowledge
of genetic variations in complex traits will improve the diagnosis, treatment and
prevention of common diseases, and how widely new pharmaceutical substances based
on the susceptibility genes could be used in public health care.
In genetic studies of obesity the discovery of leptin in 1994 (Zhang et al. 1994) had a
tremendous effect on research field. Ever since our cognizance of the mechanisms of
body weight regulation, adiposity and adipocyte metabolism as well as feeding behavior
have increased dramatically. The interplay and concerted action of hypothalamic
neurotransmitters have been elucidated with animal models and the hunt for yet
unraveled missing links continues vigorously. The genes responsible for severe human
obesity are finally starting to be elucidated, but a lot of hard work, time and good luck
are still needed before most of the susceptibility genes and predisposing alleles for the
common form of human obesity are incontestably resolved.
This thesis in its own tiny part, found significant evidence of putative genetic loci
influencing obese phenotype, and thus provides interesting pieces for the huge
ambiguous puzzle of this complex trait. This thesis also offers evidence of genetic loci
influencing another aspect of growth, i.e. body height. Yet, further studies are needed to
determine the underlying genes and alleles and their definite roles in the regulation of
body composition.
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